RNA复制子对基因表达的促进作用及动物促生长方法的探讨
摘要
本研究采用塞姆利基森林病毒(SFV)RNA复制子和微球(MP)介导基因转移技术,以期提高目的基因的表达水平。首先构建了GHRH和HBsAg-SS单基因以及GHRH-HBsAg-SS双基因RNA复制子真核表达载体,在细胞和小鼠肌肉中成功地表达了目的蛋白,且表达的HBsAg-SS具有反应原性。制备的MP-DNA复合物提高了目的基因的表达以及基因免疫水平;也证实了复制子载体对基因表达具有明显的促进作用,表达水平比普通载体高3倍,诱发抗体水平的升高也显著优于普通载体。微球介导的GHRH和HBsAg-SS基因直接转移,对小鼠和育肥猪均表现出明显的促生长作用。初步探讨了非遗传性获得的促生长机制,证实利用这项技术在大型哺乳动物产生两代间的,非遗传性生物效应的可能性。给妊娠母鼠和母猪进行GHRH和HBsAg-SS基因直接转移,后代表现出明显的促生长作用。同时也证实了GHRH与HBsAg-SS双基因共表达对动物的促生长具有协同作用。本研究为寻求高效的基因表达系统,实现对GH的双向调节,开发新一代提高动物生产性能的长效促生长制剂打下了基础。
Growth hormone(GH) administration has widespread use in livestock production to improve the efficiency of dietary nitrogen utilization while promoting greater protein accretion and milk production. Growth hormone (GH) is released in a regulated, distinctively in an impulse type. This phenomenon is under the control of the hypothalamic hormones, the functional interplay of two hypothalamic hypophysiotropic hormones, GH-releasing hormone (GHRH) and somatostatin (SS), exerting stimulatory and inhibitory influences, respectively. GHRH controls pulsatile secretion of GH, and SS controls basal secretion of GH. The gene expression of GHRH is inhibited by antagonistic action from SS. A lot of research confirm that GHRH peptide and antibodies against SS expressed in vivo by gene transfection technique can improve animal productivity. In order to cut down antagonistic action from SS and improve growth hormone level preferably, we project that expressing GHRH peptide and immune neutralizating somatostain in vivo simultaneously. It is able to implement the two-ways regulation for GH and may be a potential way to increase animal productivity.
Gene transfer technique mediated by microsperes and RNA replion were introducted to our study. The eukaryon expression vectors based RNA Replicon, pCMV-Rep-GHRH, pCMV-Rep-HBsAg-SS and pCMV-Rep-GHRH-HBsAg-SS were constructed respectively in our investigation. The interest protein that expressed in eukaryon cells and skeletal muscle of mice successfully have biological activity by detecting. The result confirmed that transgene expression from GHRH and HBsAg-SS mediated by PLGA microspheres in skeletal muscle have growth-enchancing effect significantly for mice and pigs.
We have demonstrated that pregnant rat dams treated with this system give birth to pups that have significantly increased numbers of somatotrophs and lactotrophs, as well as long-term increase in body weight and concentrations of serum IGF-I. We also have demonstrated that similar effects have been obtained in the porcine model despite a longer gestation time and different placental structure compared with the rodent model. The average birth weights, concentrations of serum IGF-I and GH, growth rate of piglets which were born to gilts that had received GHRH and HBsAg-SS plasmid were significantly heavier than control groups. The results aslo demonstrated that the enhanced gene expression, genetic immunizationand and ability protecting plasmid DNA from degraded by nuclease due to microspheres adsorption and RNA replicon may significantly promote gene expression. We can also draw another conclusion that a synergistic action is displayed between GHRH and SS from co-expression vector pCMV-Rep-GHRH-HBsAg-SS in growth-enchancing and improve immunity in mice and first-generation progeny pigs.
The vectors construction of pCMV-Rep-GHRH, pCMV-Rep-HBsAg-SS and pCMV-Rep-GHRH-HBsAg-SS. GHRH or HBsAg-SS gene fragment was obtained by PCR amplification, with addition of cohensive ends of BamHⅠsite, taking pIRES-GHRH or pIRES-HBsAg-SS plasmid as template. The plasmid pCMV-Rep-GHRH or pCMV-Rep-HBsAg-SS were constructed by inserting a GHRH or HBsAg-SS fragment into the BamHI site of pCMV-Rep-LacZ replacing LacZ gene. Transforming to competent DH10B, recombinants were selected and identified by PCR, restriction enzyme digestion, orientation and DNA sequencing were carried out to verify the recombinant plasmids pCMV-Rep-GHRH and pCMV-Rep-HBsAg-SS. BamHⅠwas located at 3′end of GHRH gene in the pIRES-GHRH-HBsAg-SS plasmid. BamHⅠand BgLⅡare isocaudarner each other. We designed primers for GHRH gene, laying EocRⅠsite in the 5′end and BgLⅡsite in the 3′end of GHRH gene. GHRH gene fragment that obtained by PCR amplification, taking pIRES-GHRH plasmid as template was digested by EocRⅠand BgLⅡ, and then were ligated to pIRES-GHRH-HBsAg-SS with the same digestion and transformed to competent DH5α. The positive recombinants were selected and identified by PCR, restriction enzyme digestion and sequencing. After identification GHRH-HBsAg-SS gene fragment was obtained by PCR amplification, taking pIRES-GHRH plasmid mutated as template with upstream primer of GHRH gene and downstream primer of HBsAg-SS gene. pCMV-Rep-GHRH-HBsAg-SS was constructed by inserting a GHRH-HBsAg-SS fragment into the BamHI site of pCMV-Rep-LacZ replacing LacZ gene. PCR, restriction enzyme digestion, orientation and DNA sequencing were carried out to verify the recombinant plasmids pCMV-Rep-GHRH-HBsAg-SS. We have demonstrated that RNA replicon-based GHRH and SS co-expression in eucaryotic cell. The three expression vectors were transfected to prepared 293 and BHK-21 cells in 80% confluent according to provided protocols by Lipofectin. Results of RT-PCR, Tricine-SDS-PAGE, Western Blot and immunofluorescence antibody assay showed the our interested gene was expressed efficiently in transfected cell. The molecular weight of interest protein were match with those of expectation. The results indicated that SS antigen determinant were exposed in the surface of fusion protein by ELISA and RIA, possessing immunogenicity. The result confirmed that RNA replicon may significantly promote gene expression. To evaluate the effects of the SFV RNA replicon on the efficiency of gene expression, LacZ gene was inserted into pIRES which digested by BamHⅠand dephosphorylated by shrimp alkaline phosphatase, creating pIRES-LacZ in the present study. RNA replicon vector pCMV-Rep-LacZ and two conventional CMV promoter-based vector pLNCX-LacZ, pIRES-LacZ were transfected to prepared cells and mice muscles respectively. RNA replicon vector pCMV-Rep-GHRH and two conventional CMV promoter-based vector pcDNA3.1-GHRH, pIRES-GHRH were transfected respectively too. RNA replicon vector pCMV-Rep-HBsAg-SS and the conventional CMV promoter-based vector pIRES-HBsAg-SS were transfected respectively too. Results of quantitating forβ-gal expressed from transfected cells, quantitating for GHRH expressed from transfected cells by RIA and RT-PCR and for SS fusion protein expressed from transfected cells by RIA, RT-PCR and RT-Real Time PCR showed that the express level of RNA replicon vector was superior to ordinary vector and 3 times as high as that of two conventional DNA vectors. The concentration of serum HBsAb, serum IGF-I and anti-SS from transfected mice were detected by RIA and ELISA in this study. The results showed that the seurm antibody level and concentration of IGF-I from mice transfected RNA replion were higher signifiantly than that from ordinary vector respectively, however growth gain were not significantly higher than those from ordinary vector.
We have demonstrated that the enhanced gene expression, genetic immunizationand and ability protecting plasmid DNA from degraded by nuclease due to microspheres adsorption. PLGA microspheres were prepared by double emulsion-in liquid evaporation process, using biodegrable ploy lactic-co-glycolic acid as carrier. The mean particle size were 10.58μm.. PLGA-MP-DNA compounds were prepared by mingling between PLGA-MP and DNA plasmid in proportion, incubated for 8~10 h at 37℃. The result that experiment for DNA protection by DNaseⅠdigestion and DNA immobilisation ability confirmed PLGA-MP-DNA compounds were able to adsorp and protect DNA plasmid. The result of mice muscular transfection in vivo showed that accumulative weight gain and concentration of serum IGF-I in the group injected with pCMV-Rep-GHRH-HBsAg-SS microspheres(40μg DNA) was significantly higher by 12.26%(P<0.01) than those groups injected with bare plasmid 35 days after injection. The anti-SS level in the group injected with plasmid microspheres were significantly higher by 10.36%(P<0.05) and 34.43%(P<0.05) than those groups injected with bare plasmid 14, 21 days after injection, respectively.
The result confirmed that promoted growth and enhanced immunity in animal due to GHRH and HBsAg-SS gene transfer mediated by PLGA-MP. Mice were treated with pCMV-Rep-GHRH-MP and pCMV-Rep-HBsAg-SS-MP(40μg plasmid)and saline-MP by muscular injection, respectively. Immunohistochemistry from muscle injected site were detected. The result confirmed that interest protein corresponding were expressed in the mice muscle. After 35 days, the accumulative weight gain in those groups treated with pCMV-Rep-GHRH-MP and pCMV-Rep-HBsAg-SS-MP were 20.69~37.27%(P<0.01)significantly higher than the group injected with saline-MP. After 3~35 days, Concentrations of serum IGF-I in those groups treated with pCMV-Rep-GHRH-MP and pCMV-Rep-HBsAg-SS-MP were higher than the group injected with saline-MP, the best one was 143.49%(P<0.01) significantly higher than control group. The result of ELISA and RIA detection for serological specificity HBsAb and anti-SS were positive. The growing-finishing pigs were treated with pCMV-Rep-GHRH-MP and pCMV-Rep-HBsAg-SS-MP(1.5 mg plasmid)and saline-MP by muscular injection, respectively. After 120 days, the accumulative weight gain in those groups treated with pCMV-Rep-HBsAg-SS-MP were 6.36%(P<0.01)significantly higher than the group injected with saline-MP. The result of ELISA and RIA detection for serological specificity HBsAb and anti-SS were positive after injected 2 week. After 14~64 days concentrations of serum IGF-I in the groups treated with plasmid MP were significantly 11.41~66.34%(P<0.01) higher than control group, one of serum GH were higher 12.49~48.68%(P<0.01), and serum SS were lower 12.49~48.68%(P<0.05). The result that lymphocyte stimulation indices and the level of swine pest antibody detected confirmed GHRH and HBsAg-SS gene transfer could improve immunity in growing-finishing pigs.
We have also demonstrated that promoted growth and enhanced immunity in first-generation progeny due to GHRH and HBsAg-SS gene transfer mediated by PLGA-MP. Pregnant rat dams were injected intramuscularly at day 14 d of gestation with 100μg of pCMV-Rep-GHRH-MP and pCMV-Rep-HBsAg-SS-MP. The result showed the born weight were significantly higher in the group treated with pCMV-Rep-HBsAg-SS-MP than the group injected with saline-MP. At day 35 after injected weight gain folds were 8.48%(P<0.05)~25.86%(P<0.01), concentrations of serum IGF-I were 31.34~56.19%(P<0.01)significantly higher in two group treatment group than control group, and serum SS in the groups treated with pCMV-Rep-HBsAg-SS-MP were lower 36.24%(P<0.01). The proportion of GH-positive cells was 43.39%~61.46%(P<0.01) significantly increased in teatment group than the control group. Gilts were injected intramuscularly at day 85~90 of gestation with 1 or 5 mg of pCMV-Rep-GHRH-MP and pCMV-Rep-HBsAg-SS-MP. Piglets were weighed from birth to weaning and bled at weaning. The result showed the weight of born, 20 d and 50 d were significantly 20.32~110.76%(P<0.01)higher than the group injected with saline-MP. After 50 days, concentrations of serum IGF-I in the groups treatmet groups with plasmid were significantly 2~3 times(P<0.01) higher than the group injected with saline-MP, one of serum GH were higher 11~26% (P<0.01).The result that lymphocyte stimulation indices and the level of swine pest antibody detected confirmed GHRH and HBsAg-SS gene transfer could improve immunity in first-generation progeny pigs.
The result confirmed that a synergistic action displayed between GHRH and SS from co-expression vector pCMV-Rep-GHRH-HBsAg-SS in growth-enchancing for animal. The results from experiment in mice showed that the accumulative weight gain in the groups treated with pCMV-Rep-GHRH-HBsAg-SS-MP were 12.80~13.74%(P<0.01)significantly higher than those group injected with pCMV-Rep-GHRH-MP and pCMV-Rep-HBsAg-SS-MP at day 35 after injected. At 3 and 35 day, concentrations of serum IGF-I in the groups treated with pCMV-Rep-GHRH-HBsAg-SS-MP were 29.19~141.26%(P<0.05) significantly higher than injected with single gene plasimd group. The results from experiment in first-generation progeny mice showed that weight in double genes groups were 5.02(P>0.05)~16.02%(P<0.05)and the proportion of GH-positive cells was 9.09~13.01%(P<0.05)significantly highter in teatment group than single gene group after 59 d born. Gilts were injected intramuscularly at day 85~90 of gestation with 5 mg of pCMV-Rep-GHRH-HBsAg-SS-MP. Weight at weaning, serum IGF-I and GH, lymphocyte stimulation indices and the level of swine pest antibody were significantly higher than single gene group. The results from this study substantiated that GHRH and SS co-expression displayed synergistic action about growth-enchancing and improve immunity in mice and progeny pigs.
Growth hormone(GH) administration has widespread use in livestock production to improve the efficiency of dietary nitrogen utilization while promoting greater protein accretion and milk production. Growth hormone (GH) is released in a regulated, distinctively in an impulse type. This phenomenon is under the control of the hypothalamic hormones, the functional interplay of two hypothalamic hypophysiotropic hormones, GH-releasing hormone (GHRH) and somatostatin (SS), exerting stimulatory and inhibitory influences, respectively. GHRH controls pulsatile secretion of GH, and SS controls basal secretion of GH. The gene expression of GHRH is inhibited by antagonistic action from SS. A lot of research confirm that GHRH peptide and antibodies against SS expressed in vivo by gene transfection technique can improve animal productivity. In order to cut down antagonistic action from SS and improve growth hormone level preferably, we project that expressing GHRH peptide and immune neutralizating somatostain in vivo simultaneously. It is able to implement the two-ways regulation for GH and may be a potential way to increase animal productivity.
Gene transfer technique mediated by microsperes and RNA replion were introducted to our study. The eukaryon expression vectors based RNA Replicon, pCMV-Rep-GHRH, pCMV-Rep-HBsAg-SS and pCMV-Rep-GHRH-HBsAg-SS were constructed respectively in our investigation. The interest protein that expressed in eukaryon cells and skeletal muscle of mice successfully have biological activity by detecting. The result confirmed that transgene expression from GHRH and HBsAg-SS mediated by PLGA microspheres in skeletal muscle have growth-enchancing effect significantly for mice and pigs.
We have demonstrated that pregnant rat dams treated with this system give birth to pups that have significantly increased numbers of somatotrophs and lactotrophs, as well as long-term increase in body weight and concentrations of serum IGF-I. We also have demonstrated that similar effects have been obtained in the porcine model despite a longer gestation time and different placental structure compared with the rodent model. The average birth weights, concentrations of serum IGF-I and GH, growth rate of piglets which were born to gilts that had received GHRH and HBsAg-SS plasmid were significantly heavier than control groups. The results aslo demonstrated that the enhanced gene expression, genetic immunizationand and ability protecting plasmid DNA from degraded by nuclease due to microspheres adsorption and RNA replicon may significantly promote gene expression. We can also draw another conclusion that a synergistic action is displayed between GHRH and SS from co-expression vector pCMV-Rep-GHRH-HBsAg-SS in growth-enchancing and improve immunity in mice and first-generation progeny pigs.
The vectors construction of pCMV-Rep-GHRH, pCMV-Rep-HBsAg-SS and pCMV-Rep-GHRH-HBsAg-SS. GHRH or HBsAg-SS gene fragment was obtained by PCR amplification, with addition of cohensive ends of BamHⅠsite, taking pIRES-GHRH or pIRES-HBsAg-SS plasmid as template. The plasmid pCMV-Rep-GHRH or pCMV-Rep-HBsAg-SS were constructed by inserting a GHRH or HBsAg-SS fragment into the BamHI site of pCMV-Rep-LacZ replacing LacZ gene. Transforming to competent DH10B, recombinants were selected and identified by PCR, restriction enzyme digestion, orientation and DNA sequencing were carried out to verify the recombinant plasmids pCMV-Rep-GHRH and pCMV-Rep-HBsAg-SS. BamHⅠwas located at 3′end of GHRH gene in the pIRES-GHRH-HBsAg-SS plasmid. BamHⅠand BgLⅡare isocaudarner each other. We designed primers for GHRH gene, laying EocRⅠsite in the 5′end and BgLⅡsite in the 3′end of GHRH gene. GHRH gene fragment that obtained by PCR amplification, taking pIRES-GHRH plasmid as template was digested by EocRⅠand BgLⅡ, and then were ligated to pIRES-GHRH-HBsAg-SS with the same digestion and transformed to competent DH5α. The positive recombinants were selected and identified by PCR, restriction enzyme digestion and sequencing. After identification GHRH-HBsAg-SS gene fragment was obtained by PCR amplification, taking pIRES-GHRH plasmid mutated as template with upstream primer of GHRH gene and downstream primer of HBsAg-SS gene. pCMV-Rep-GHRH-HBsAg-SS was constructed by inserting a GHRH-HBsAg-SS fragment into the BamHI site of pCMV-Rep-LacZ replacing LacZ gene. PCR, restriction enzyme digestion, orientation and DNA sequencing were carried out to verify the recombinant plasmids pCMV-Rep-GHRH-HBsAg-SS. We have demonstrated that RNA replicon-based GHRH and SS co-expression in eucaryotic cell. The three expression vectors were transfected to prepared 293 and BHK-21 cells in 80% confluent according to provided protocols by Lipofectin. Results of RT-PCR, Tricine-SDS-PAGE, Western Blot and immunofluorescence antibody assay showed the our interested gene was expressed efficiently in transfected cell. The molecular weight of interest protein were match with those of expectation. The results indicated that SS antigen determinant were exposed in the surface of fusion protein by ELISA and RIA, possessing immunogenicity. The result confirmed that RNA replicon may significantly promote gene expression. To evaluate the effects of the SFV RNA replicon on the efficiency of gene expression, LacZ gene was inserted into pIRES which digested by BamHⅠand dephosphorylated by shrimp alkaline phosphatase, creating pIRES-LacZ in the present study. RNA replicon vector pCMV-Rep-LacZ and two conventional CMV promoter-based vector pLNCX-LacZ, pIRES-LacZ were transfected to prepared cells and mice muscles respectively. RNA replicon vector pCMV-Rep-GHRH and two conventional CMV promoter-based vector pcDNA3.1-GHRH, pIRES-GHRH were transfected respectively too. RNA replicon vector pCMV-Rep-HBsAg-SS and the conventional CMV promoter-based vector pIRES-HBsAg-SS were transfected respectively too. Results of quantitating forβ-gal expressed from transfected cells, quantitating for GHRH expressed from transfected cells by RIA and RT-PCR and for SS fusion protein expressed from transfected cells by RIA, RT-PCR and RT-Real Time PCR showed that the express level of RNA replicon vector was superior to ordinary vector and 3 times as high as that of two conventional DNA vectors. The concentration of serum HBsAb, serum IGF-I and anti-SS from transfected mice were detected by RIA and ELISA in this study. The results showed that the seurm antibody level and concentration of IGF-I from mice transfected RNA replion were higher signifiantly than that from ordinary vector respectively, however growth gain were not significantly higher than those from ordinary vector.
We have demonstrated that the enhanced gene expression, genetic immunizationand and ability protecting plasmid DNA from degraded by nuclease due to microspheres adsorption. PLGA microspheres were prepared by double emulsion-in liquid evaporation process, using biodegrable ploy lactic-co-glycolic acid as carrier. The mean particle size were 10.58μm.. PLGA-MP-DNA compounds were prepared by mingling between PLGA-MP and DNA plasmid in proportion, incubated for 8~10 h at 37℃. The result that experiment for DNA protection by DNaseⅠdigestion and DNA immobilisation ability confirmed PLGA-MP-DNA compounds were able to adsorp and protect DNA plasmid. The result of mice muscular transfection in vivo showed that accumulative weight gain and concentration of serum IGF-I in the group injected with pCMV-Rep-GHRH-HBsAg-SS microspheres(40μg DNA) was significantly higher by 12.26%(P<0.01) than those groups injected with bare plasmid 35 days after injection. The anti-SS level in the group injected with plasmid microspheres were significantly higher by 10.36%(P<0.05) and 34.43%(P<0.05) than those groups injected with bare plasmid 14, 21 days after injection, respectively.
The result confirmed that promoted growth and enhanced immunity in animal due to GHRH and HBsAg-SS gene transfer mediated by PLGA-MP. Mice were treated with pCMV-Rep-GHRH-MP and pCMV-Rep-HBsAg-SS-MP(40μg plasmid)and saline-MP by muscular injection, respectively. Immunohistochemistry from muscle injected site were detected. The result confirmed that interest protein corresponding were expressed in the mice muscle. After 35 days, the accumulative weight gain in those groups treated with pCMV-Rep-GHRH-MP and pCMV-Rep-HBsAg-SS-MP were 20.69~37.27%(P<0.01)significantly higher than the group injected with saline-MP. After 3~35 days, Concentrations of serum IGF-I in those groups treated with pCMV-Rep-GHRH-MP and pCMV-Rep-HBsAg-SS-MP were higher than the group injected with saline-MP, the best one was 143.49%(P<0.01) significantly higher than control group. The result of ELISA and RIA detection for serological specificity HBsAb and anti-SS were positive. The growing-finishing pigs were treated with pCMV-Rep-GHRH-MP and pCMV-Rep-HBsAg-SS-MP(1.5 mg plasmid)and saline-MP by muscular injection, respectively. After 120 days, the accumulative weight gain in those groups treated with pCMV-Rep-HBsAg-SS-MP were 6.36%(P<0.01)significantly higher than the group injected with saline-MP. The result of ELISA and RIA detection for serological specificity HBsAb and anti-SS were positive after injected 2 week. After 14~64 days concentrations of serum IGF-I in the groups treated with plasmid MP were significantly 11.41~66.34%(P<0.01) higher than control group, one of serum GH were higher 12.49~48.68%(P<0.01), and serum SS were lower 12.49~48.68%(P<0.05). The result that lymphocyte stimulation indices and the level of swine pest antibody detected confirmed GHRH and HBsAg-SS gene transfer could improve immunity in growing-finishing pigs.
We have also demonstrated that promoted growth and enhanced immunity in first-generation progeny due to GHRH and HBsAg-SS gene transfer mediated by PLGA-MP. Pregnant rat dams were injected intramuscularly at day 14 d of gestation with 100μg of pCMV-Rep-GHRH-MP and pCMV-Rep-HBsAg-SS-MP. The result showed the born weight were significantly higher in the group treated with pCMV-Rep-HBsAg-SS-MP than the group injected with saline-MP. At day 35 after injected weight gain folds were 8.48%(P<0.05)~25.86%(P<0.01), concentrations of serum IGF-I were 31.34~56.19%(P<0.01)significantly higher in two group treatment group than control group, and serum SS in the groups treated with pCMV-Rep-HBsAg-SS-MP were lower 36.24%(P<0.01). The proportion of GH-positive cells was 43.39%~61.46%(P<0.01) significantly increased in teatment group than the control group. Gilts were injected intramuscularly at day 85~90 of gestation with 1 or 5 mg of pCMV-Rep-GHRH-MP and pCMV-Rep-HBsAg-SS-MP. Piglets were weighed from birth to weaning and bled at weaning. The result showed the weight of born, 20 d and 50 d were significantly 20.32~110.76%(P<0.01)higher than the group injected with saline-MP. After 50 days, concentrations of serum IGF-I in the groups treatmet groups with plasmid were significantly 2~3 times(P<0.01) higher than the group injected with saline-MP, one of serum GH were higher 11~26% (P<0.01).The result that lymphocyte stimulation indices and the level of swine pest antibody detected confirmed GHRH and HBsAg-SS gene transfer could improve immunity in first-generation progeny pigs.
The result confirmed that a synergistic action displayed between GHRH and SS from co-expression vector pCMV-Rep-GHRH-HBsAg-SS in growth-enchancing for animal. The results from experiment in mice showed that the accumulative weight gain in the groups treated with pCMV-Rep-GHRH-HBsAg-SS-MP were 12.80~13.74%(P<0.01)significantly higher than those group injected with pCMV-Rep-GHRH-MP and pCMV-Rep-HBsAg-SS-MP at day 35 after injected. At 3 and 35 day, concentrations of serum IGF-I in the groups treated with pCMV-Rep-GHRH-HBsAg-SS-MP were 29.19~141.26%(P<0.05) significantly higher than injected with single gene plasimd group. The results from experiment in first-generation progeny mice showed that weight in double genes groups were 5.02(P>0.05)~16.02%(P<0.05)and the proportion of GH-positive cells was 9.09~13.01%(P<0.05)significantly highter in teatment group than single gene group after 59 d born. Gilts were injected intramuscularly at day 85~90 of gestation with 5 mg of pCMV-Rep-GHRH-HBsAg-SS-MP. Weight at weaning, serum IGF-I and GH, lymphocyte stimulation indices and the level of swine pest antibody were significantly higher than single gene group. The results from this study substantiated that GHRH and SS co-expression displayed synergistic action about growth-enchancing and improve immunity in mice and progeny pigs.
引文
[1] Frolov I,Hoffman T A,Pragai B M,et al. Alphavirus-based expression vectors:strategies and applications. Proc Natl Acad Sci USA,1996,93(21):11371-11377
[2] DiCiommo D P,Bremner R. Rapid high level protein production using DNA-based Semliki Forest virus vectors. J Biol Chem,1998,273(29):18060-18066
[3] Leitner W W,Han Ying,David A,et al. Enhancement of Tumor-specific Immune Response with Plasmid DNA Replicon Vectors.Cancer Research,2000,60(1):51-55
[4] Elke S,Wolfgang W. Danger death and DNA vaccines. Microbes and Infection,2004,6:319-327
[5] Mangala J,avid A,Kay T. DNA Immunization against Herpes Simplex Virus:Enhanced Efficacy Using a Sindbis Virus-Based Vector. Journal of Virology,1998,72(2):950-958
[6] Schlesinger S. Alphavirus vectors:development and potential therapeutic applications. Expert Opin Biol Ther,2001,1(2):177-191
[7] 余云舟,俞炜源.黄病毒属病毒复制子载体研究进展.生物技术通讯,2006,17(2):228~231
[8] K??ri?inen L,S?derlund H. Structure and replication of alpha-viruses. Curr Top Microbiol Immunol,1978,82:15-69
[9] 仇华吉,李卫平,童光志.RNA 复制子疫苗.中国生物工程杂志,2003,23(3):44~49
[10] Ker?nen S,Ruohonen L. Nonstructural proteins of Semliki Forest virus:synthesis,processing,and stability in infected cells. J Virol,1983,47(3):505-515
[11] Poch O,Sauvaget J,Delarue M,et al. Identification of four conserved motifs among the RNA dependent polymerase encoding protein. EMBO J ,1989,8(12):3867-3874
[12] Koonin E V,Dolja V V. Evolution and taxonomy of positive-strand RNA viruses:Implications of comparative analysis of amino acid sequences. Crit RevBiochem Mol Biol,1993,28:375-430
[13] Keranen S,Kaariainen L. Functional defects of RNA-negative temperature- sensitive mutants of Sindbis and Semliki Forest viruses. J Virol,1979,32(1):19-29
[14] LaStarza,M W,Lemm J A,Rice C M,et al. Genetic analysis of the nsP3 region of Sindbis virus:Evidence for roles in minusstrand and subgenomic RNA synthesis. J Virol,1994,68:5781-5791
[15] Wang Y F,Sawicki S G,Sawicki D L. Alphavirus nsP3 functions to form replication complexes transcribing negative-strand RNA. J Virol,1994,68:6466-6475
[16] Vihinen,H,T Ahola,M Tuittila,et al. Elimination of phosphorylation sites of Semliki Forest virus replicase protein nsP3. J. Biol. Chem,2001,276:5745-5752
[17] Hardy W R,Strauss J H. Processing the nonstructural polyproteins of Sindbis virus:Nonstructural proteinase is in the C-terminal half of nsP2 and functions both in cis and in trans. J Virol,1989,63:4653-4664
[18] Gorbalenya A E,Koonin E V,Lai M C,et al. Putative papain-related thiol proteases of positive-strand RNA viruses. Identification of rubi- and aphtovirus proteases and delineation of a novel conserved domain associated with proteases of rubi-,alpha- and coronaviruses. FEBS Lett,1991,288:201-205
[19] Gorbalenya A E,Koonin E V. Helicases:amino acid sequence comparisons and structure-function relationships. Curr Opin Cell Biol,1993,3:419-429
[20] Hahn Y S,Strauss E G,Strauss J H. Mapping of RNA- temperature-sensitive mutants of Sindbis virus:Assignment of complementation groups A,B,and G to nonstructural proteins. J Virol,1989,63:3142-3150
[21] Suopanki J D L,Sawicki S G,Sawicki,et al. Regulation of alphavirus26S mRNA transcription by replicase component nsP2. J Gen Virol,1998,79:309-319
[22] Levis R,Schlesinger S,H V Huang. Promoter for Sindbis virus RNA-dependent subgenomic RNA transcription. J Virol,1990,64(4):1726-1733
[23] Raju R,Huang H V. Analysis of Sindbis virus promoter recognition in vivo,using novel vectors with two subgenomic mRNA promoters. J Virol,1991,65(5):2501-2510
[24] Weiss B,Nitschko H,Ghattas I,et al. Evidence for specificity. in the encapsidation of Sindbis virus RNAs. J Virol,1989,63:5310-5318
[25] 侯云德,主编.分子病毒学.第 2 版,北京:学苑出版社,1990:430~435
[26] Strauss J H,Strauss E G. Alphaviruses. Microbiol Rev,1994,58:491-562
[27] 方美玉,林立辉,任瑞文.我国甲病毒的研究进展.中华流行病学杂志,2003,24(11):1060~1063
[28] Davis N I,Willis L W,Smith J F,et al. In vitro synthesis of infectious Venezuelan equine encephalitis virus RNA from a cDNA clone:analysis of a viable deletion mutant. Virology,1989,171(1):189-204
[29] Rice C M,Levis R,Strauss J H,et al. Production of infectious RNA transcripts from Sindbis virus Cdna clones:mapping Jf lethal mutations,rescue of a temperature sensitive marker,and in vitro mutagenesis to generate defined mutants. J Virol,1987,61:3809-3819
[30] Hang C S,Hang Y S,Braciale T J,et al. Infectious sindbis virus transient expression vectors for studying antigen processing and presentation. PNAS,1992,89(4):2679-2683
[31] Liljestrom P,Garoff H. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio Technology,1991,9:1356-1361
[32] Kohno A,Emi N,Kasai M,et al. Semliki Forest virus-based DNA expression vector:transient protein production followed by cell death. Gene Ther,1998,5(3):415-418
[33] Meanger J,Peroulis I,Mills J. Modified Semliki forest virus expression vector that facilitates cloning. Bio Techniques,1997,23(3):432-435
[34] Schlesinger,S. Alphaviruses-vectors for the expression of heterologous genes. Trends Biotechnol,1993,11:18-22
[35] 谢京国,方六荣,肖少波.双基因共表达的“自杀性”DNA 疫苗载体的改造及其体外表达特性,中国兽医学报.2006,26(6):583~590
[36] Xiong C,Levis R,Shen P,et al. Sindbis virus:an efficient,broad host range vector for gene exp ression in animal cells. Science,1989,243(3):1188-1191
[37] 何海怀,梁国栋.辛德毕斯病毒载体的研究进展.病毒学报,2001,17(1):93~96
[38] 周鹏,聂奎.甲病毒载体研究进展.中国生物制品学杂志,2006,19(4):430~433
[39] HerweiJer H,Latendresse J S,Williams P,et al. A plasmid based self amplifying Sindbis virus vector. Hum GeneTher,1995,6:1161-1167
[40] Hariharan M J,Driver D,To Wnsend K,et al. DNA immuniza tion against herpessimplex virus:enhanced efficacy using a Sindbis virus based vector. J Virol,1998,72:950-958
[41] Leitner W W,Han Y,Nicholas P R. DNA and RNA-based vaccines:principles,progress and prospects. Vaccine,2000,18:765-777
[42] Blasey,H D,Brethon B,Hovius R,et al. Large scale transient 5-HT3 receptor production with the Semliki Forest virus expression. Cytotechnology,2000,32,199-208
[43] Ciccarone V. Heterologous protein expression inmammalian cells with the SFV gene expression system. Focus,1994,16:94-96
[44] Boorsma M,Nieba L,Koller D,et al. A temperature-regulated replicon-based DNA expression system. Nat Biotechnol,2000,18(7):429-432
[45] Lundstrom K,Abenavoli A,Malgaroli A,et al. Novel Semliki Forest virus vectors with reduced cytotoxicity and temperature sensitivity for long-term enhancement of transgene expression.Mol Ther,2003,7(2):7202-7209
[46] Olkkonen V M. Expression of heterologous proteins in cultured rat hippocampal neurons. Using the Semliki Forest virus vector. J Neurosci Res,1993,35:445-451
[47] 许信刚,李健强.核酸疫苗研究的进展.畜禽业,2001,136(8):16~18
[48] Ying H,Tai Z,Zarks,Rong Fu Wang,et al. Cancer therpy using a self replicating RNA vaccine. Nature Medine,1999,5(7):823-827
[49] Berglund P,Smerdou C,Fleeton M N,et al. Enhancing immune responses using suicidal DNA Vaccine. NatBiotechnol,1998,16(6):562-565
[50] Liljeqvist S,Stahl S. Production of recombinant subunit vaccines:protein immunogens,live delivery systems and nucleic acid vaccines. Journal of Biotechnology,1999,73:11-33
[51] Fleeton M N,Liljestr?m P,Sheahan B J,et al. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protectiveresponse than plasmid-based DNA vaccines or and inactivated whole particle vaccine. Journal of General Virology,2000,81:749-758
[52] Leitner W W ,Hwang L N ,Deveer M J ,et al. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med,2003,9:33-39
[53] Zhou X,Berglund P,Rhodes G,et al. Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine,1994,12:1510-1514
[54] 方六荣,陈焕春,肖少波,等.猪繁殖与呼吸综合征病毒 ORF5 基因“自杀性”DNA 疫苗的初步研究.中国预防兽医学报,2002,24:259~263
[55] Onate A A,Donoso G,Moraga Cid G,et al. An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase p rotein of Brucella abortus induces p rotective immunity in BALB/c mic. Infect Immun,2005,73(6):3294-3300
[56] 邓瑶,孟昕,许洪林.Semliki 森林病毒衍生的 DNA 疫苗与常规 DNA 疫苗的比较.病毒学报,2002,18(4):328~330
[57] 张健慧,Jens Wild,Kurt Bieler.传统 DNA 疫苗载体与 Semliki 森林病毒复制子对 HIV1Pr55gag 表达与体液免疫原性的比较性研究.病毒学报,2002,18(1):5~9
[58] 倪兵,吴玉章.小鼠肥大细胞瘤基因疫苗的免疫治疗作用研究.第三军医大学学报,2002,24(10):1140~1142
[59] 陈水平,秦鄂德.我国 D243 病毒株 PrM E 基因的复制型载体质粒 DNA 的免疫原性研究.中国生物化学与分子生物学报,2002,18(2):151~155
[60] Hsu K F,Hung C F. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein70 to anantigen. Gene Therapy,2001,8(5):376-383
[61] Schlesinger S.Alphavirus expression vectors. Adv Virus Res,2000,55:565-570
[62] Weiss B,Rosenthal R,Schlesinger S. Establishment and maintenance of persistent infection by Sindbis virus in BHK cells. J Virol,1980,33(1):463-474
[63] 张小青,裘霁,丁明孝,等.Sindbis 病毒的繁殖与宿主细胞 BHK21 的凋亡.微生物学报,1997,37(3):165~170
[64] Lundstrom K,Rotmann D,Hermann D,et al. Novel mutant Semliki Forest virus vectors:Gene expression and localization studies in neuronal cells. HistochemCell Biol,2001,115(10):83-91
[65] Céline Rhême1,Markus U,Ehrengruber. Alphaviral cytotoxicity and its implication in vector development. Experimental Physiology,2005,90(1):45-52
[66] Olkkonen V M,Liljestr?m P,Garoff H,et al. Rapid Communication Expression of heterologous proteins in cultured rat hippocampal neurons using the semliki forest virus vector. Journal of Neuroscience Research,2004,35(4):445-451
[67] Ehrengruber M U,Lundstrom K,Schweitzer C,et al. Recombinant Semliki Forest virus and Sindbis virus efficiently infect neuronsin hippocampal slice cultures. Proc Natl Acad Sci,1999,96:7041-7046
[68] Murphy A M,Morris Downes,M M,Sheahan B J,et al. Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles. Gene Ther,2000,7:1477-1482
[69] Tseng J C,Levin B,Hurtado A,et al. Systemic tumor targeting and killing by Sindbis viral vectors. Nat Biotechnol,2004,22(1):70-77
[70] 倪兵,杨日高,李艳秋.基于重组 α 病毒的基因疫苗对小鼠肥大细胞瘤 P815的防治作用.细胞与分子免疫学杂志,2004,20(1):45~48
[71] Stacie M Goldberg,Shirley M Bartido,Jason P Gardner,et al. Comparison of Two Cancer Vaccines Targeting Tyrosinase:Plasmid DNA and Recombinant Alphavirus Replicon Particles. Clin Cancer Res,2005,11(22):8114-8121
[72] Cheng W F,Lee C N,Y N Su,et al. Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity. Cancer Gene Therapy,2006,13:873-885
[73] Mathiot C C,Grimaud G,Garry P,et al. An outbreak of human Semliki Forest virus infections in Central African Republic. Am. J. Trop. Med. Hyg,1990,42:386-393
[74] Mossman S P,Bex F,Berglund P,et al. Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol,1996,70:1953-1960
[75] Berglund P,Sjaberg M,Garoff H,et al. Semliki Forest virus expression system:production of conditionally infectious recombinant particles. Bio Technology,1993,11:916-920
[76] Smerdou C,Liljestrêm P. Two-helper RNA system for p roduction of recombinant Semliki Forest virus particles. J Virol,1999,73(2):1092-1098
[77] Kojima M,Hosoda H,Date Y,et al. ghrelin is a growthhormone-releasing acylated peptide from stomach. Nature,1999,402(6762):656-660
[78] Reichlin S. Growth hormone content of pituitaries from rats with hypothalamic lesions. Endocrinology,1961,69:225-230
[79] Frantz A V , Bonneau M . Growth factors and productivity in swine breeding. Growth hormone-releasing factor and perinatal growth hormone releasing factor,steroids,beta-agonists,somatotropin. Biofutur Jun,1962,18(5):95-97
[80] Frantz A V,Heimer E P,Felix A M,et al. There was a factor increases growth hormone levels in the rat. Proc Natl Acad Sei USA,1964,91(2):782 786
[81] Schally R S,Hashizume T,Kanematsu S. Effects of growth hormone releasing factor on the release of growth hormone in pigs. Domest Anim Endocrinol,1971,7(4):451-456
[82] Guillemin R,Brazeau P,Bohlen P,et al. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science,1982,218:585-587
[83] Rivier J,Spiess J,Thorner M,et al. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour . Nature,1982,300:276-278
[84] Bohlen P,Brazeau P,Bloch B,et al. Human hypothalamic growth hormone releasing factor(GHRH):evidence for two forms identical to tumor derived GHRH-44-NH2 and GHRH-40. Biochem Biophys Res Commun,1983,114(3):930-936
[85] Spiess J,Rivier J,Vale W. Characterization of rat hypothalamic growth hormone releasing factor . Nature,1983,303:532-535
[86] Ling N,Esch F,Bohlem P,et al. Isolation,primary structure,and synthesis of human hypothalamic somatocrinin. Proc Nall Acad Sci USA,1984,81:4302-4306
[87] Brazeau P,Bohlen P,Esch F,et al. Growth hormone-releasing factor from ovine and caprine hypothalamus : isolation , sequence analysis and totalsynthesis. Biochem Biophys Res Commun,1984,125(2):606-614
[88] Bohlen P F Esch,Brazeau P,et al. Isolation and characterization of the porcine hypothalamic growth hormone releasing factor. Biochem Biophys Res Commun,1983,116(116):726-734
[89] Esch F,P Bohlen,Ling N,et al. Isolation and characterization of the bovine hypothalamic growth hormone releasing factor. Biochem Biophys Res Commun,1983,117(3):772-779
[90] Bohlen P F Esch,Wehrenberg W B,et al. Rat hypothalamic growth hormone-releasing factor : isolation , sequence analysis and total synthesis. Biochem Biophys Res Commun,1984,125(3):1005-1012
[91] Bloch B,Brazeau P,Ling N,Immunohistochemical detection of growth hormone-releasing factor in brain.Nature,1983,301(5901):607-608
[92] Endo H,Yamaguchi M,Farnsworth R. et al. Mouse placental cells secrete immunoreactive growth hormone-releasing factor. Boil Reprod,1994 ,51(6):1206-1212
[93] Olchovsky D,Bruno J F,Berelowitz M. Growth hormone-releasing factor expression is discordantly regulated in the hypothalamus and testis of streptozotocin-diabetic rats. J Endocrino,1996,148(2):189-192
[94] SA Berry,C H Srivastava,L R Rubin. Growth hormone-releasing hormone-like messenger ribonucleic acid and immunoreactive peptide are present in human testis and placenta. The Journal of Clinical Endocrinology & Metabolism,1992,75,281-284
[95] Zsuzsanna Kahán,José M Arencibia,Valér J Csernus. Expression of Growth Hormone-Releasing Hormone(GHRH)Messenger Ribonucleic Acid and the Presence of Biologically Active GHRH in Human Breast,Endometrial,and Ovarian Cancers. The Journal of Clinical Endocrinology & Metabolism,1999,84(2):582-589
[96] Paul Brazeau,Peter B?hlen,Frederick Esch. Growth hormone-releasing factor from ovine and caprine hypothalamus:Isolation,sequence analysis and total synthesis. Biochemical and Biophysical Research Communications, 1984,125(2):606-614
[97] Mayo K E,Cerelli G M,Lebo R N,et al. Gene encoding human growth hormone releasing factor precursor : structure , sequence and chromosomal assignment. Proc Natl Acad Sci USA,1985,82:63-67
[98] Chan Gling. European Patent,0459747A116
[99] Blerman K. European Patent,0509831A16
[100] Prez Jurado L A,Phillips J A 3rd,Summar M L,et al. Genetic mapping of the human growth hormone-releasing factor gene(GHRF)using two intragenic polymorphisms detected by PCR amplification. Genomics,1994,20(1):132-134
[101] Ling N. Synthesis and in vivo bioactivity of human growth releasing factor analogs substituted at position-1. Biochem Biophys Res Comm,1984,122:304~309
[102] Ling N,Baird A,Wehrenberg W B,et al. Synthesis and in vitro bioactivity of C-terminal deleted analogs of human growth hormone-releasing factor. Biochem Biophys Res Commun,1984,123(2):854-861
[103] Boulanger L,Lazure C,Lefrancois L,et al. Proteolytic degradation of rat growth hormone-releasing factor(1-29)amide in rat pituitary and hypothalamus. Brain Res,1993,616(12):39-47
[104] Su C M,Jensen L R,Heimer E P,et al. In vitro stability of growth hormone releasing factor(GHRH)analogs in porcine plasma. Horm Metab Res,1991,23(1):15-21
[105] Boulanger L,Roughly P,Gaudreau P,et al. Catabolism of rat growth hormone-releasing factor(1-29)amide in rat serum and liver. Peptides,1992,13681-13689
[106] Kubiak T M,Kelly C R,Krabill L F,et al. In vitro metabolic degradation of a bovine growth hormone-releasing factor analog Leu27-bGHRH(1-29)NH2 in bovine and porcine plasma Correlation with plasma dipeptidylpeptidase activity. Drug Metab Dispos,1989,17(4):393-397
[107] Bowers C Y,Reynold G A,Cheng D,et al. A study on the regulation of growth hormone releasing from the pituitaries of rats in vitro. Endocrinology,1981,108(3):1071-1080
[108] Kubiak T M,Friedman A R,Martin R A,et al. Position2 and position2/Ala15-substituted analogs of bovine growth hormone-releasing factor(bGHRH)with enhanced metabolic stability and improved in vivobioactivity. J Med Chem,1993,36:888-897
[109] Campbell R M,Stricker P,Miller R,et al. Enhanced stability and potency of novel growth hormone-releasing factor(GHRH)analogues derived from rodent and human GHRH sequences. Peptides,1994,15:489-495
[110] Lucie Jetté , Roger Léger , Karen Thibaudeau , Human Growth Hormone-Releasing Factor(hGHRH)1-29-Albumin Bioconjugates Activate the GHRH Receptor on the Anterior Pituitary in Rats: Identification of CJC-1295 as a Long-Lasting GHRH Analog. Endocrinology,2004,146(7):3052-3058
[111] 冯立文,张永亮,刘松财,等.生长激素释放因子(GHRH)的基因改造及化学合成.中国兽医学报,1998,18(6):520~522
[112] Sun H S,Tarlor C,Robic A,et al. Mapping of growth hormone releasing hormone receptor to swine chromosome18. Anim Genet,1997,28:351-353
[113] Gaylinn,B D,C. von Kap-Herr,Golden W L,et al. Assignment of the human growth hormone-releasing hormone receptor gene(GHRHR)to 7p14 by in situ hybridization. Genomics,1994,19:193-195
[114] Krulich L,Dharival A P,McCann S M.Stimulatory and inhibitory effeect of Purified hypothalamic extracts in growth hormone release from rat pituitary in vito. Endocrinology,1968,83:783-790
[115] Brazeau P,Vale W,Burgus R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science,1973,179:77-79
[116] Rondeel J M,Jackson I M. Molecular biology of the regulation of hypothalamic hormones. J Endocrinol Invest,1993,16(3):219-246
[117] Goodman R H,Jacobs J W,Chin W W,et al. Nucleotide sequence of a cloned structural gene coding for a precursorof a pancreatic somatostatin. Proc Natl Acad Sci USA,1982,77:1682
[118] Chisholm C G,ReenbeRg G R. Somatostatin28 Regulates GLP1secretion via somatostatin receptor subtype 5 in rat intestinal cultures. Am J Physiol Endocrinol Metab,2002,283(2):311-317
[119] MitRa S W,Mezey E,Hunyady B,et al. Colocalization of somatostatin receptor SS5 and insulin in rat pancreatic β cell. Endocrinology,1999,140:3790-3796
[120] Pfeiffe R M,Koch T,SchRode R H,et al. Homo and heterodimerization of somatostatin receptor subtypes. J Biol Chem,2001,276(17):14027-14036
[121] Rocheville M,Lange D C,Kuma R U,et al. Receptors fo Rdopamine and somatostatin : formation of hetero oligomers with enhanced function alactivity. Science,2000,288(5463):154-157
[122] AfaRgan M,Janson E T,Gelerman G,et al. Novel long acting soma tostatin analog with endocrine selectivity:potent suppression of growth hormone but not of insulin . Endocrinology,2001,142:477-486
[123] Rajeswa RanW G,Hoca Rt S J,MuRphy W A, et al. Highly potent and subtype selective ligands derived by N-methylscan of a somatostatin an tagonist. J Med Chem,2001,44:1305-1311
[124] Belanger A,Labrie F,Borgeat P,et al. Immer H. Inhibition of growth hormone and thyrotropin release by growth hormone-release inhibiting hormone. Mol Cell Endocrinol,1974,1(5):329-339
[125] Kaneko T,Oka H,Munemure M,et al. Stimulation of guanosine 3',5’-cyclic monophosphate accumulation in rat anterior pituitary gland in vitro by synthetic somatostatin. Biochem Biophys Res Commun,1974,61(1):53-57
[126] Plotsky P M,Vale W. Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science,1985,230(4724):461-463
[127] Hodate K,Jhke T,Ozawa A,et al. Plasma growth hormone,insulin-like growth factor I , and milk production responses toe xogenous human growth hormone-releasing factor analogs in dairy cows . Endocrinol J pn,1990,37(2):261-273
[128] Pelletier G,Petitclerc D,Lapierre H,et al. Injection of synthetic human growth hormone-releasing factor in dairy cows.Effect on feed intake and milk yield and composition. J Dairy Sci,1987,70(12):2511-2517
[129] Enright W J,Zinn S A,Chapin L T. Growth hormone response of bull calves to growth hormone releasing factor.Proc Soc Exp Biol Med,1987,184(4):483-488
[130] Lapierre H,Tyrrell H F,Reynolds C K,et al. Effects on growth hormone-releasing factor and feed intake on energy metabolismin growing beefsteers:whole-body energy and nitrogen metabolis. J Anim Sci,1992,70(3):764-772
[131] Farmer C,Pommier S A,Brazeau P. Validation of a culture system for porcine pituitary cells:effects of growth hormone-releasing factor and(or)somatostatin on growth hormone secretion. J anim Sci,1993,71(4):923-929
[132] Dubreuil P,Petitclerc D,Pelletier G,et al. Effect of dose and frequency of administration of a potent analog of human growth hormone-releasing factor on hormone secretion and growth in pigs. J Anim Sci,1990,68(5):1254-1268.
[133] Johnson J T,Coffey M T,Esbenshade K L,et al. The effect of human growth hormone-releasing factor or porcine somatotropin on serum hormones and metabolites,growth performance and carcass traits in swine. J Anim Sci,1990,68(10):3204-3211
[134] Pommier S A,Dubreuil P,Pelletier G,et al. Effect of a potent analog of human growth hormone-releasing factor on carcass composition and quality of crossbred market pigs. J Anim Sci,1990,68(5):1291-1298
[135] Draghia-Akli R,Li X G,Schwartz R J. Enhanced Growth by ectopic expression of Growth hormone releasing hormone using an injectabele myogenic vector. Nat Biotechnol,1997,15:1285-1289
[136] Rusandra D A. Ecoptic GHRH Gene Expressed in Muscle and Increased Growth. Natur Biotech,1997,15:1285-1289
[137] Draghia-Akli R,Robert J A,Rusandra D A,et al.Myogenic expressed in muscle and increased Growth. Nature Biotechnol,1999,15:1179-1183
[138] 张永亮,欧阳红生,刘松财,等.生长激素释放因子(GHRH)在动物肌肉组织的表达.中国兽医学报,2000,(3):239~242
[139] 白忠彬,张永亮,田宝磊,等.原生质体介导的外源性 GHRH 基因在家兔体内的表达.华中农业大学学报,2002,21(6):509~511
[140] 任晓慧,张永亮,刘松财,等.微球包裹 pcDNA3-GHRH(1-32)在小鼠肌肉组织的表达及对生长的影响.生物工程学报,2004,20(4):615~618
[141] 张勇,周安国,吴德,等.仔猪骨骼肌注射 pGHRH 基因质粒的促生长及代谢调控效应研究.畜牧兽医学报,2003,34(2):147~151
[142] Khan,A S,Fiorotto M L,Cummings K K,et al. Maternal GHRH plasmid administration changes pituitary cell lineage and improves progeny growth ofpigs. Am. J. Physiol. Endocrinol. Metab,2003,285:224-231
[143] Draghia-Akli R,Fiorotto M L. A new plasmid-mediated approach to supplement somatotropin production in pigs. J. Anim. Sci,2004,82:264-269
[144] Meng Q Y,Chen Z Q,Yu Z Q,et al. Increased Body Weight Via Injecting Myogenic Expression Growth Hormone-Releasing Hormone(GHRH)Plasmid DNA into Sheep. Animal Biotechnology,2004,15(2):175-192
[145] 张利宇,孙宝忠,王敏.导入外源 GHRH 基因质粒对犊牛生长性能的影响.畜牧兽医科学,2006,22(9):10~13
[146] Fadlalla A M,Spencer G S G. The effect on passive immuniza -tion on against somatostatin on marker retention time in lambs. Journal of Animal Science,1985,61(1):234-238
[147] Maccecchini M L. Method of promoting animal growth using antibodies against somatostatin. U S Patent:4599,299.1986,7-8
[148] Sun Y X,Sinclair S E,Wynn P C,et al. Immunization against somatotrophn release inhibiting factor improves digestibity of food,growth and wool prodction of crossbred lambs. Aust J Agri Res,1990,41:401-411
[149] McCauley I,Billinghurst A,Morgan P O,et al. Manipulation of endogenou hormones to increase growth. Australasian Pig Science Association,1995:52-61
[150] Van Kessel A G,Laarveld B. Effect of passive immunization against somatostatin using a high-affinity antiserum on growth,IGF- I and thyroid hormone levels in neonatal lambs reared under warm or cold environmental conditions. Can J Anim Sci,1994,74:23-27
[151] Lawrence M E,Scheling G T,Byers F M,et al. Improvement of growth and feed efficiency in cattle by active immunization against somatostatin. J Anm Sci,1986,63(suppl):215
[152] Ingvartsen K L,Sejrsen K. Effect of immunization against somatatatin(ss)in cattle:a review of performance carcass composition and possible mode of action. Acta Agri Scandinavica(Section Animal Science),1995,45(45):124-131
[153] Trout W E,Schanbacher B D. Growth hormone and insulinlike growth factor-1 responses in steers actively immunized against somatostatin or growthhormone-releasing factor. J Endocrinol,1990,125:123-129
[154] Vicini J L,Clark J H,Hurley W L,et al. The effect of immunization against somatostatin on growth and concentration of somatotropin in plasma of Holstein calves. Domest Anim Endocrinol,1988,15(1):35-45
[155] Spencer G S G,Williamson E D. Increased growth of following irnmunization against somatostatin preliminary observations. Animal production,1981,32:376-383
[156] Spencer G S G. A novel approcehtogrouth promotion using auto immunisation against somatostatinIEffects on frowth an dhormone levels in lambs Livestock Priduction Science,1983(10):25-27
[157] Deligeorgis S G,Rogdakis E,Mentzios A,et al. Anote on the effect of active immunization against somatostatin on milk production and growth in sheep. Anim Prod,1988,46:304-308
[158] Van Kessel A G,Laarveld B,Acute or chronic immunoneutralization of somatostatin does not effect growth hormone or thyroid hormone secretion in sheep. J Endoc,1993,136:261-269
[159] Spencer G S G. Immuno-neutralization of somatostatin(ss) and its effects on animal production. Anim. Endocrinol,1986,3:55-68
[160] Mears G J. Immunization of lambs against somatostatin improve growth rate. Can J Anim Sci,1990,70:1091-1097
[161] Hoskinson R M,Djura P,Welch R J,et al. Failure of antisomatostatin antibodies to stimulate the growth of crossbred lambs. Aust J Exper Agri,1988,1222:1717-1725
[162] Varner M A,Davi S L,Reeves J J. Temporal serum concentrations of growth hrmone , thygrotropin , insulin glucagon in sheep immunized against somatoatatin. Endocrinology,1980,106:1027-1032
[163] 黄夺先,姚连生,赵伟,等.生长抑素主动免疫山羊的增重效果.江苏农业学报,1991,7(4):37~40
[164] Spencer G S G,Harvey S,Audsley A R,et al. The effect of immunization against somatostatin on growth rates and growth hormone secretion in the chicken. Comp Biochem Physiol A,1986,85(3):553-556
[165] Buonomo F C,Sabacky M J,Della-Fera M A,et al. Effects of somatostatinimmunoneutralization on growth and endocrine parameters in chickens. Domest Anim Endocrinol,1987,4(3):191-200
[166] Westbrook S L,Chandler K D,Mcdowell G H. Immunization of pregnant ewes against somatotrophin release inhibiting factor increases growth of twin-lambs. Aust J Agri Res,1993,44:229-238
[167] Westbrook S L,Ali A M,Mcdowell G H. Passively-acquired antibodies to somatostropin release inhibiting factor increases appetite and growth of milk-fed lambs. Aust J Agric Res,1994,45:293-302
[168] Farmer C,Dubreuil P,Pettclerc G,et a1. Active immunization against somatostatin in gestating gilts and the effect of transferred immunity on piglets. Can J Anim Sci,1990,70:211-218
[169] 曾义祥,杜念兴,汤锦炎.生长抑制激素基因在大肠杆菌中的表达.遗传学报,1991,18(3):282~288
[170] 徐文忠,李光地.生长抑素基因初级克隆质粒(pUC12—SS)的改造与鉴定.南京农业大学学报,1991,14(3):83~86
[171] 徐文忠,杜念兴,李光地,等.生长抑素基因与乙肝病毒表面抗原基因融合体质粒(pUC12-ss/HBs)的构建.南京农业大学学报,1992,15(02):83~88
[172] 徐文忠,杜念兴,李光地,等.促进动物生长的新型基因工程疫苗研究.中国科学 B 辑,1993,23(12):1272~1278
[173] 徐文忠,陈萍,杜念兴.基因重组痘苗病毒在鸡胚中的增殖与表达.南京农业大学学报,1994,17(2):126~127
[174] 蔡云珠,周建斌,邵长发,等.激生Ⅰ号免疫中国美利奴羊的增重试验.畜牧与兽医,2000,32(3):25~26
[175] 杜念兴,杨宏,吉传义,等.生长抑素基因工程苗活载体疫苗田间试验总结初报.畜牧与兽医,2001,33(2):23~24
[176] 王恩秀,陈伟华,杜念兴.生长抑素基因工程疫苗对大鼠生长及免疫的影响.中国兽医学报,2002,22(5):427~429
[177] 杜念兴,杨永军,王林云,等.激生Ⅰ号免疫中国美利奴羊的增重试验.畜牧与兽医,2000,32(3):25~26
[178] 孙元膀,王寿宽,赵中兴,等.激生 1 号疫苗免疫育肥猪低营养水平饲养增重试验.畜牧与兽医,2001(2):24~25
[179] 蔡云珠,王林云,杜念兴,等.一种新型的生长抑素活载体基因工程苗的构建及其动物免疫小试.中国畜牧杂志,1999,35(6):59~60
[180] 苏香林,李峰,王双.激生 1 号对生长育肥猪生长效果的试验观察.畜牧与兽医,2003(5):18~21
[181] 周鹏,严国祥,王全昌,等.激生 1 号免疫三元杂交肉猪的效果.畜牧与兽医,2003(2):18~19
[182] 王春凤,黄波,韦毕芬,等.激生 1 号免疫“内三元”育肥猪低能饲粮饲养试验.养猪,2006,2:24~25
[183] 骆永胜,林兆京.激生 1 号免疫三元杂交肉猪的试验报告.畜禽业,2005,8:32~33
[184] 徐国栋,刘长辉,李智红,等.“激生Ⅰ号”疫苗对猪增重效果的观察.2003,20,(5):61~62
[185] 莫晓群,崔治中,杜念兴.乙肝表面抗原和生长抑素融合基因在杆状病毒中表达.农业生物技术学报,1995,2:69~74
[186] 刘永庆,刘文波,潘杰彦,等.生长抑素(SS)基因在 pET-32 表达系统中的高效表达.南京农业大学学报,2003,26(1):61~65
[187] 刘永庆,陈溥言,杜念兴,等.生长抑素(SS)与硫氧还原蛋白(Thioredoxin)相融合生成的 2 种基因工程化融合蛋白 SS-N/X 和 SS-N/S 的表达特性.中国兽医学报,2003,23(2):172~176
[188] 陈溥言,杜念兴,赵国屏,等.生长抑素(SS)基因在大肠杆菌 pT7ZZ 表达系统中的克隆与表达.中国生物制品学杂志,2002,15(1):17~20
[189] 刘永庆,潘杰彦,陈溥言,等.生长抑素基因在大肠杆菌 pThioHis 表达系统中的克隆与表达.中国生物制品学杂志,2003,16(1):19~23
[190] 舒邓群,茆达干,吴志敏,等.以减毒沙门氏菌为载体的 GM-CSF 与生长抑素融合表达质粒对小鼠淋巴细胞增殖和 GH 及 IGF-Ⅰ分泌的影响.畜牧兽医学报,2006,37(8):814~818
[191] 戴贤君,方维焕.减毒沙门氏菌为载体的草鱼口服生长抑素 DNA 疫苗的构建及其稳定性.中国兽医学报,2005,25(4):356~358
[192] 何勤,张志荣,刘戟,等.载 TK 基因聚丙交酯乙交酯纳米粒的制备及有关性质研究.生物医学工程学杂志,2002,19(1):30~33
[193] 戴建威,刘松财,任晓慧,等.生长抑素与乙肝表面抗原真核表达载体构建及其对 Vc 獭兔生长的影响.中国兽医学报,2006,26(1):1~4
[194] 任晓慧,张永亮,刘松财,等.微球介导 GRF 基因在小鼠肌肉组织的表达及对增重的影响.生物工程学报,2004,20(4):615~618
[195] 张悦,戚晓红,冯振卿,等.免疫佐剂的研究进展.中国血吸虫病防治杂志,2004,16(3):236~238
[196] Xiao-Wen He,Fang Wang,Lei Jiang,et al. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg. Journal of General Virology,2005,86,601-610
[197] Lima K M,Santos S A,Lima V M,et al. Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis. Gene Ther,2003,10(8):678-685
[198] 刘松财,任晓慧,张明军,等.生长激素释放因子和垂体腺苷酸环化酶激活肽基因的共表达.科技导报,2006,24(8):36~39
[199] 杨瑞丽,金勇丰,吴玉澄,等.乙肝病毒表面抗原(HBsAg)基因工程疫苗的研究进展.药物生物技术,2002,9(1):53~56
[200] Valenzuela P,Medina A,Ruter W J. Synthesis and assembly of Hepatitis B virus surface antigen particles in yeast. Nature,1982,298:347-350
[201] Basu M,Dharm E,Levine J F,et al. Expression of Growth Homone-releasing Factor Analog Leu27GHRH(1-44)In Escherichia coli : Purification and Characterization of the Expresssed Protein. Arch. Biochem. Biophys.,1991,286(2):638-644
[202] Masahiro Iwakura,Kazuhiko Obara,Tomokuni Kokubu,et al. Expression and purification of Growth Hormone-releasing Factor With the Aid of Dihydrofolate Reductase Handle. J. Biochem.,1992,112:57-62
[203] 李伯良.牛生长激素释放因子的融合表达及其产物的化学加工.生物化学与生物物理学报,1994,26(6):577~583
[204] 王晓华,张娜,张娟辉,等.重组生长激素释放激素 GHRH 的纯化及活性测定.军医大学学报,2004,24(3):321~324
[205] Mehigh C S,Elias V D,Mehigh R J,et al. Development of a Recombinant Bovine Leukemia Vector for Delivery of a Synthetic Bovine Growth Hormone-releasing Factor Gene Into Bovine Cells. J Anim Sci,1993,71(3):687-693
[206] 曹少先,杨利国,茆达干,等.生长抑素基因疫苗 pcS/SS 构建及其在 HeLa细胞中的表达.中国兽医学报,2004,24(2):153~155
[207] Boyer J C,Haenni A L. Infectious transcripts and cDNA clones of RNA viruses. Virology,1994,198(2):415-426
[208] 余云舟,孙志伟,刘志刚,等.基于 DNA 的 Semliki 森林病毒复制子载体体内外高水平表达外源基因.生物化学与生物物理进展,2006,33(1):87~94
[209] 龚非,姜述德,李卫东,等.生物可降解微球作为乙型肝炎基因免疫佐剂的研究.微生物学通报,2001,28(2):68~72
[210] 胡云霞,原续波,康春生,等.同载基因和药物的超微载体粒子的制备及体外评价.高分子通报,2004,4:69~72
[211] 何勤,张志荣,刘戟,等.载 TK 基因聚丙交酯乙交酯纳米粒的性质及表达研究.药学学报,2004,39(4):285~287
[212] Corre P L,Guevello P L,Gajan v,et al. Preparation and characterization of bupivacaine-loaded polylactide and polylactide-co-glycolide micrpspheres. Int J Pharm,1994,107(1):41-49
[213] 金爱华,张寅恭,焦捷军,等.丙交酯乙交酯共聚物的毒性试验及其含左旋 18-甲基炔诺酮微球对鼠的抗生育作用研究.生物医学工程学杂志,2000,17(2):125~128
[214] Alpaslan C,Irie K,Takahashi K,et al. Long-term evaluation of recombinant human bone morphogenetic protein-induced bone formation with a biologic and synthetic delivery system. Br Joral and max illofac Surg,1996,34(5):414-418
[215] 刘善奎,高申,钟延强,等.DNA 疫苗微球给药系统的研究进展.中国药学杂志,2003,38(11):828~831
[216] Panyam J,Zhou W Z,Prabha S,et al. Rapid endo-lysosomal escape of poly(DL-lactide-coglycolide)nanoparticles : implications for drug and gene delivery. The FASEB Journal,2002,16:1217-1226
[217] Breier B H,Gluckman P D,Bass J J. Influence of status and oestradiol-17β on plasma growth hormone,Insulin-like factor-I and -II and response to exogenous growth hormone. Endocrinology,1988,118:243-250
[218] Draghia-Akli R. Myogenic expression of an injectable protease-resistant growth hormone-release hormone augments long-term growth in pigs. Natural Biotechnology,1999,17(1):51-54
[219] 任晓慧.GHRP-6和pcDNA3-GRF缓释微球的制备及对动物生长的影响:[硕士学位论文].长春:中国人民解放军军需大学,2004
[220] 王子荣,任明强,胥清富,等.生长抑素基因工程苗对绵羊外周血液某些代谢物浓度和激素水平的影响.畜牧兽医学报,2004,35(4):404~408
[221] Varner M A,Davis S L,Reeves J J. Temporal serum concent rat ions of growth hormone,thyroropin insulin and glucagon in sheep immunized against somatostat in. Endocrino logy,1980,106:1027-1032
[222] Trout W E,Schanbacher B D. Grow th hormone and insulin-like growth factor-I responses in steers actively immunized against somatostatin or growth hormone-releasing factor. Journal of Endocrinology,1990,125:123-129
[223] Dawson J M ,Soar J B,But tery P J,et al. The effect of immunization against somatostat in and B2agonist administ rat ion alone and in combination on grow th and carcass composition in young steers. Anim Sci,1997,64:37-51
[224] Magnan E,Mazzocchi L,Cataldi M,et al. Effect of actively immunizing sheep against rowth hormone releasing hormone or somatostatin on spontaneous pulsatile and neostigmine-induced growth hormone secretion.Endocrinology,1995,144:83-90
[225] Rehfeldt C,Kuhn G. Consequences of birth weight for postnatal growth performance and carcass quality in pigs as related to myogenesis. J Anim Sci,2006,84:113-123
[226] Harkins M,Boyd R D,and Bauman D E. Effect of recombinant porcine somatotropin on lactational performance and metabolite patterns in sows and growth of nursing pigs. J Anim Sci,1989,67:1997-2008
[227] Brown P A,Davis W C,Draghia-Akli R,et al. Immune-enhancing effects of growth hormone-releasing hormone delivered by plasmid injection and electroporation. Mol Ther,2004,10(4):644-651
[228] Thacker E L,Holtkamp D J,Khan A S,et al. Plasmid-mediated growth hormone-releasing hormone efficacy in reducing disease associated with Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus infection. J Anim Sci,2006,84:733-742
[229] 刘根桃,郑元林,陈伟华,等.妊娠后期母猪饲喂大豆黄酮对泌乳性能及初乳中激素水平的影响.南京农业大学学报,1998,22(1):69~71
[2] DiCiommo D P,Bremner R. Rapid high level protein production using DNA-based Semliki Forest virus vectors. J Biol Chem,1998,273(29):18060-18066
[3] Leitner W W,Han Ying,David A,et al. Enhancement of Tumor-specific Immune Response with Plasmid DNA Replicon Vectors.Cancer Research,2000,60(1):51-55
[4] Elke S,Wolfgang W. Danger death and DNA vaccines. Microbes and Infection,2004,6:319-327
[5] Mangala J,avid A,Kay T. DNA Immunization against Herpes Simplex Virus:Enhanced Efficacy Using a Sindbis Virus-Based Vector. Journal of Virology,1998,72(2):950-958
[6] Schlesinger S. Alphavirus vectors:development and potential therapeutic applications. Expert Opin Biol Ther,2001,1(2):177-191
[7] 余云舟,俞炜源.黄病毒属病毒复制子载体研究进展.生物技术通讯,2006,17(2):228~231
[8] K??ri?inen L,S?derlund H. Structure and replication of alpha-viruses. Curr Top Microbiol Immunol,1978,82:15-69
[9] 仇华吉,李卫平,童光志.RNA 复制子疫苗.中国生物工程杂志,2003,23(3):44~49
[10] Ker?nen S,Ruohonen L. Nonstructural proteins of Semliki Forest virus:synthesis,processing,and stability in infected cells. J Virol,1983,47(3):505-515
[11] Poch O,Sauvaget J,Delarue M,et al. Identification of four conserved motifs among the RNA dependent polymerase encoding protein. EMBO J ,1989,8(12):3867-3874
[12] Koonin E V,Dolja V V. Evolution and taxonomy of positive-strand RNA viruses:Implications of comparative analysis of amino acid sequences. Crit RevBiochem Mol Biol,1993,28:375-430
[13] Keranen S,Kaariainen L. Functional defects of RNA-negative temperature- sensitive mutants of Sindbis and Semliki Forest viruses. J Virol,1979,32(1):19-29
[14] LaStarza,M W,Lemm J A,Rice C M,et al. Genetic analysis of the nsP3 region of Sindbis virus:Evidence for roles in minusstrand and subgenomic RNA synthesis. J Virol,1994,68:5781-5791
[15] Wang Y F,Sawicki S G,Sawicki D L. Alphavirus nsP3 functions to form replication complexes transcribing negative-strand RNA. J Virol,1994,68:6466-6475
[16] Vihinen,H,T Ahola,M Tuittila,et al. Elimination of phosphorylation sites of Semliki Forest virus replicase protein nsP3. J. Biol. Chem,2001,276:5745-5752
[17] Hardy W R,Strauss J H. Processing the nonstructural polyproteins of Sindbis virus:Nonstructural proteinase is in the C-terminal half of nsP2 and functions both in cis and in trans. J Virol,1989,63:4653-4664
[18] Gorbalenya A E,Koonin E V,Lai M C,et al. Putative papain-related thiol proteases of positive-strand RNA viruses. Identification of rubi- and aphtovirus proteases and delineation of a novel conserved domain associated with proteases of rubi-,alpha- and coronaviruses. FEBS Lett,1991,288:201-205
[19] Gorbalenya A E,Koonin E V. Helicases:amino acid sequence comparisons and structure-function relationships. Curr Opin Cell Biol,1993,3:419-429
[20] Hahn Y S,Strauss E G,Strauss J H. Mapping of RNA- temperature-sensitive mutants of Sindbis virus:Assignment of complementation groups A,B,and G to nonstructural proteins. J Virol,1989,63:3142-3150
[21] Suopanki J D L,Sawicki S G,Sawicki,et al. Regulation of alphavirus26S mRNA transcription by replicase component nsP2. J Gen Virol,1998,79:309-319
[22] Levis R,Schlesinger S,H V Huang. Promoter for Sindbis virus RNA-dependent subgenomic RNA transcription. J Virol,1990,64(4):1726-1733
[23] Raju R,Huang H V. Analysis of Sindbis virus promoter recognition in vivo,using novel vectors with two subgenomic mRNA promoters. J Virol,1991,65(5):2501-2510
[24] Weiss B,Nitschko H,Ghattas I,et al. Evidence for specificity. in the encapsidation of Sindbis virus RNAs. J Virol,1989,63:5310-5318
[25] 侯云德,主编.分子病毒学.第 2 版,北京:学苑出版社,1990:430~435
[26] Strauss J H,Strauss E G. Alphaviruses. Microbiol Rev,1994,58:491-562
[27] 方美玉,林立辉,任瑞文.我国甲病毒的研究进展.中华流行病学杂志,2003,24(11):1060~1063
[28] Davis N I,Willis L W,Smith J F,et al. In vitro synthesis of infectious Venezuelan equine encephalitis virus RNA from a cDNA clone:analysis of a viable deletion mutant. Virology,1989,171(1):189-204
[29] Rice C M,Levis R,Strauss J H,et al. Production of infectious RNA transcripts from Sindbis virus Cdna clones:mapping Jf lethal mutations,rescue of a temperature sensitive marker,and in vitro mutagenesis to generate defined mutants. J Virol,1987,61:3809-3819
[30] Hang C S,Hang Y S,Braciale T J,et al. Infectious sindbis virus transient expression vectors for studying antigen processing and presentation. PNAS,1992,89(4):2679-2683
[31] Liljestrom P,Garoff H. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio Technology,1991,9:1356-1361
[32] Kohno A,Emi N,Kasai M,et al. Semliki Forest virus-based DNA expression vector:transient protein production followed by cell death. Gene Ther,1998,5(3):415-418
[33] Meanger J,Peroulis I,Mills J. Modified Semliki forest virus expression vector that facilitates cloning. Bio Techniques,1997,23(3):432-435
[34] Schlesinger,S. Alphaviruses-vectors for the expression of heterologous genes. Trends Biotechnol,1993,11:18-22
[35] 谢京国,方六荣,肖少波.双基因共表达的“自杀性”DNA 疫苗载体的改造及其体外表达特性,中国兽医学报.2006,26(6):583~590
[36] Xiong C,Levis R,Shen P,et al. Sindbis virus:an efficient,broad host range vector for gene exp ression in animal cells. Science,1989,243(3):1188-1191
[37] 何海怀,梁国栋.辛德毕斯病毒载体的研究进展.病毒学报,2001,17(1):93~96
[38] 周鹏,聂奎.甲病毒载体研究进展.中国生物制品学杂志,2006,19(4):430~433
[39] HerweiJer H,Latendresse J S,Williams P,et al. A plasmid based self amplifying Sindbis virus vector. Hum GeneTher,1995,6:1161-1167
[40] Hariharan M J,Driver D,To Wnsend K,et al. DNA immuniza tion against herpessimplex virus:enhanced efficacy using a Sindbis virus based vector. J Virol,1998,72:950-958
[41] Leitner W W,Han Y,Nicholas P R. DNA and RNA-based vaccines:principles,progress and prospects. Vaccine,2000,18:765-777
[42] Blasey,H D,Brethon B,Hovius R,et al. Large scale transient 5-HT3 receptor production with the Semliki Forest virus expression. Cytotechnology,2000,32,199-208
[43] Ciccarone V. Heterologous protein expression inmammalian cells with the SFV gene expression system. Focus,1994,16:94-96
[44] Boorsma M,Nieba L,Koller D,et al. A temperature-regulated replicon-based DNA expression system. Nat Biotechnol,2000,18(7):429-432
[45] Lundstrom K,Abenavoli A,Malgaroli A,et al. Novel Semliki Forest virus vectors with reduced cytotoxicity and temperature sensitivity for long-term enhancement of transgene expression.Mol Ther,2003,7(2):7202-7209
[46] Olkkonen V M. Expression of heterologous proteins in cultured rat hippocampal neurons. Using the Semliki Forest virus vector. J Neurosci Res,1993,35:445-451
[47] 许信刚,李健强.核酸疫苗研究的进展.畜禽业,2001,136(8):16~18
[48] Ying H,Tai Z,Zarks,Rong Fu Wang,et al. Cancer therpy using a self replicating RNA vaccine. Nature Medine,1999,5(7):823-827
[49] Berglund P,Smerdou C,Fleeton M N,et al. Enhancing immune responses using suicidal DNA Vaccine. NatBiotechnol,1998,16(6):562-565
[50] Liljeqvist S,Stahl S. Production of recombinant subunit vaccines:protein immunogens,live delivery systems and nucleic acid vaccines. Journal of Biotechnology,1999,73:11-33
[51] Fleeton M N,Liljestr?m P,Sheahan B J,et al. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protectiveresponse than plasmid-based DNA vaccines or and inactivated whole particle vaccine. Journal of General Virology,2000,81:749-758
[52] Leitner W W ,Hwang L N ,Deveer M J ,et al. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med,2003,9:33-39
[53] Zhou X,Berglund P,Rhodes G,et al. Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine,1994,12:1510-1514
[54] 方六荣,陈焕春,肖少波,等.猪繁殖与呼吸综合征病毒 ORF5 基因“自杀性”DNA 疫苗的初步研究.中国预防兽医学报,2002,24:259~263
[55] Onate A A,Donoso G,Moraga Cid G,et al. An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase p rotein of Brucella abortus induces p rotective immunity in BALB/c mic. Infect Immun,2005,73(6):3294-3300
[56] 邓瑶,孟昕,许洪林.Semliki 森林病毒衍生的 DNA 疫苗与常规 DNA 疫苗的比较.病毒学报,2002,18(4):328~330
[57] 张健慧,Jens Wild,Kurt Bieler.传统 DNA 疫苗载体与 Semliki 森林病毒复制子对 HIV1Pr55gag 表达与体液免疫原性的比较性研究.病毒学报,2002,18(1):5~9
[58] 倪兵,吴玉章.小鼠肥大细胞瘤基因疫苗的免疫治疗作用研究.第三军医大学学报,2002,24(10):1140~1142
[59] 陈水平,秦鄂德.我国 D243 病毒株 PrM E 基因的复制型载体质粒 DNA 的免疫原性研究.中国生物化学与分子生物学报,2002,18(2):151~155
[60] Hsu K F,Hung C F. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein70 to anantigen. Gene Therapy,2001,8(5):376-383
[61] Schlesinger S.Alphavirus expression vectors. Adv Virus Res,2000,55:565-570
[62] Weiss B,Rosenthal R,Schlesinger S. Establishment and maintenance of persistent infection by Sindbis virus in BHK cells. J Virol,1980,33(1):463-474
[63] 张小青,裘霁,丁明孝,等.Sindbis 病毒的繁殖与宿主细胞 BHK21 的凋亡.微生物学报,1997,37(3):165~170
[64] Lundstrom K,Rotmann D,Hermann D,et al. Novel mutant Semliki Forest virus vectors:Gene expression and localization studies in neuronal cells. HistochemCell Biol,2001,115(10):83-91
[65] Céline Rhême1,Markus U,Ehrengruber. Alphaviral cytotoxicity and its implication in vector development. Experimental Physiology,2005,90(1):45-52
[66] Olkkonen V M,Liljestr?m P,Garoff H,et al. Rapid Communication Expression of heterologous proteins in cultured rat hippocampal neurons using the semliki forest virus vector. Journal of Neuroscience Research,2004,35(4):445-451
[67] Ehrengruber M U,Lundstrom K,Schweitzer C,et al. Recombinant Semliki Forest virus and Sindbis virus efficiently infect neuronsin hippocampal slice cultures. Proc Natl Acad Sci,1999,96:7041-7046
[68] Murphy A M,Morris Downes,M M,Sheahan B J,et al. Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles. Gene Ther,2000,7:1477-1482
[69] Tseng J C,Levin B,Hurtado A,et al. Systemic tumor targeting and killing by Sindbis viral vectors. Nat Biotechnol,2004,22(1):70-77
[70] 倪兵,杨日高,李艳秋.基于重组 α 病毒的基因疫苗对小鼠肥大细胞瘤 P815的防治作用.细胞与分子免疫学杂志,2004,20(1):45~48
[71] Stacie M Goldberg,Shirley M Bartido,Jason P Gardner,et al. Comparison of Two Cancer Vaccines Targeting Tyrosinase:Plasmid DNA and Recombinant Alphavirus Replicon Particles. Clin Cancer Res,2005,11(22):8114-8121
[72] Cheng W F,Lee C N,Y N Su,et al. Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity. Cancer Gene Therapy,2006,13:873-885
[73] Mathiot C C,Grimaud G,Garry P,et al. An outbreak of human Semliki Forest virus infections in Central African Republic. Am. J. Trop. Med. Hyg,1990,42:386-393
[74] Mossman S P,Bex F,Berglund P,et al. Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol,1996,70:1953-1960
[75] Berglund P,Sjaberg M,Garoff H,et al. Semliki Forest virus expression system:production of conditionally infectious recombinant particles. Bio Technology,1993,11:916-920
[76] Smerdou C,Liljestrêm P. Two-helper RNA system for p roduction of recombinant Semliki Forest virus particles. J Virol,1999,73(2):1092-1098
[77] Kojima M,Hosoda H,Date Y,et al. ghrelin is a growthhormone-releasing acylated peptide from stomach. Nature,1999,402(6762):656-660
[78] Reichlin S. Growth hormone content of pituitaries from rats with hypothalamic lesions. Endocrinology,1961,69:225-230
[79] Frantz A V , Bonneau M . Growth factors and productivity in swine breeding. Growth hormone-releasing factor and perinatal growth hormone releasing factor,steroids,beta-agonists,somatotropin. Biofutur Jun,1962,18(5):95-97
[80] Frantz A V,Heimer E P,Felix A M,et al. There was a factor increases growth hormone levels in the rat. Proc Natl Acad Sei USA,1964,91(2):782 786
[81] Schally R S,Hashizume T,Kanematsu S. Effects of growth hormone releasing factor on the release of growth hormone in pigs. Domest Anim Endocrinol,1971,7(4):451-456
[82] Guillemin R,Brazeau P,Bohlen P,et al. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science,1982,218:585-587
[83] Rivier J,Spiess J,Thorner M,et al. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour . Nature,1982,300:276-278
[84] Bohlen P,Brazeau P,Bloch B,et al. Human hypothalamic growth hormone releasing factor(GHRH):evidence for two forms identical to tumor derived GHRH-44-NH2 and GHRH-40. Biochem Biophys Res Commun,1983,114(3):930-936
[85] Spiess J,Rivier J,Vale W. Characterization of rat hypothalamic growth hormone releasing factor . Nature,1983,303:532-535
[86] Ling N,Esch F,Bohlem P,et al. Isolation,primary structure,and synthesis of human hypothalamic somatocrinin. Proc Nall Acad Sci USA,1984,81:4302-4306
[87] Brazeau P,Bohlen P,Esch F,et al. Growth hormone-releasing factor from ovine and caprine hypothalamus : isolation , sequence analysis and totalsynthesis. Biochem Biophys Res Commun,1984,125(2):606-614
[88] Bohlen P F Esch,Brazeau P,et al. Isolation and characterization of the porcine hypothalamic growth hormone releasing factor. Biochem Biophys Res Commun,1983,116(116):726-734
[89] Esch F,P Bohlen,Ling N,et al. Isolation and characterization of the bovine hypothalamic growth hormone releasing factor. Biochem Biophys Res Commun,1983,117(3):772-779
[90] Bohlen P F Esch,Wehrenberg W B,et al. Rat hypothalamic growth hormone-releasing factor : isolation , sequence analysis and total synthesis. Biochem Biophys Res Commun,1984,125(3):1005-1012
[91] Bloch B,Brazeau P,Ling N,Immunohistochemical detection of growth hormone-releasing factor in brain.Nature,1983,301(5901):607-608
[92] Endo H,Yamaguchi M,Farnsworth R. et al. Mouse placental cells secrete immunoreactive growth hormone-releasing factor. Boil Reprod,1994 ,51(6):1206-1212
[93] Olchovsky D,Bruno J F,Berelowitz M. Growth hormone-releasing factor expression is discordantly regulated in the hypothalamus and testis of streptozotocin-diabetic rats. J Endocrino,1996,148(2):189-192
[94] SA Berry,C H Srivastava,L R Rubin. Growth hormone-releasing hormone-like messenger ribonucleic acid and immunoreactive peptide are present in human testis and placenta. The Journal of Clinical Endocrinology & Metabolism,1992,75,281-284
[95] Zsuzsanna Kahán,José M Arencibia,Valér J Csernus. Expression of Growth Hormone-Releasing Hormone(GHRH)Messenger Ribonucleic Acid and the Presence of Biologically Active GHRH in Human Breast,Endometrial,and Ovarian Cancers. The Journal of Clinical Endocrinology & Metabolism,1999,84(2):582-589
[96] Paul Brazeau,Peter B?hlen,Frederick Esch. Growth hormone-releasing factor from ovine and caprine hypothalamus:Isolation,sequence analysis and total synthesis. Biochemical and Biophysical Research Communications, 1984,125(2):606-614
[97] Mayo K E,Cerelli G M,Lebo R N,et al. Gene encoding human growth hormone releasing factor precursor : structure , sequence and chromosomal assignment. Proc Natl Acad Sci USA,1985,82:63-67
[98] Chan Gling. European Patent,0459747A116
[99] Blerman K. European Patent,0509831A16
[100] Prez Jurado L A,Phillips J A 3rd,Summar M L,et al. Genetic mapping of the human growth hormone-releasing factor gene(GHRF)using two intragenic polymorphisms detected by PCR amplification. Genomics,1994,20(1):132-134
[101] Ling N. Synthesis and in vivo bioactivity of human growth releasing factor analogs substituted at position-1. Biochem Biophys Res Comm,1984,122:304~309
[102] Ling N,Baird A,Wehrenberg W B,et al. Synthesis and in vitro bioactivity of C-terminal deleted analogs of human growth hormone-releasing factor. Biochem Biophys Res Commun,1984,123(2):854-861
[103] Boulanger L,Lazure C,Lefrancois L,et al. Proteolytic degradation of rat growth hormone-releasing factor(1-29)amide in rat pituitary and hypothalamus. Brain Res,1993,616(12):39-47
[104] Su C M,Jensen L R,Heimer E P,et al. In vitro stability of growth hormone releasing factor(GHRH)analogs in porcine plasma. Horm Metab Res,1991,23(1):15-21
[105] Boulanger L,Roughly P,Gaudreau P,et al. Catabolism of rat growth hormone-releasing factor(1-29)amide in rat serum and liver. Peptides,1992,13681-13689
[106] Kubiak T M,Kelly C R,Krabill L F,et al. In vitro metabolic degradation of a bovine growth hormone-releasing factor analog Leu27-bGHRH(1-29)NH2 in bovine and porcine plasma Correlation with plasma dipeptidylpeptidase activity. Drug Metab Dispos,1989,17(4):393-397
[107] Bowers C Y,Reynold G A,Cheng D,et al. A study on the regulation of growth hormone releasing from the pituitaries of rats in vitro. Endocrinology,1981,108(3):1071-1080
[108] Kubiak T M,Friedman A R,Martin R A,et al. Position2 and position2/Ala15-substituted analogs of bovine growth hormone-releasing factor(bGHRH)with enhanced metabolic stability and improved in vivobioactivity. J Med Chem,1993,36:888-897
[109] Campbell R M,Stricker P,Miller R,et al. Enhanced stability and potency of novel growth hormone-releasing factor(GHRH)analogues derived from rodent and human GHRH sequences. Peptides,1994,15:489-495
[110] Lucie Jetté , Roger Léger , Karen Thibaudeau , Human Growth Hormone-Releasing Factor(hGHRH)1-29-Albumin Bioconjugates Activate the GHRH Receptor on the Anterior Pituitary in Rats: Identification of CJC-1295 as a Long-Lasting GHRH Analog. Endocrinology,2004,146(7):3052-3058
[111] 冯立文,张永亮,刘松财,等.生长激素释放因子(GHRH)的基因改造及化学合成.中国兽医学报,1998,18(6):520~522
[112] Sun H S,Tarlor C,Robic A,et al. Mapping of growth hormone releasing hormone receptor to swine chromosome18. Anim Genet,1997,28:351-353
[113] Gaylinn,B D,C. von Kap-Herr,Golden W L,et al. Assignment of the human growth hormone-releasing hormone receptor gene(GHRHR)to 7p14 by in situ hybridization. Genomics,1994,19:193-195
[114] Krulich L,Dharival A P,McCann S M.Stimulatory and inhibitory effeect of Purified hypothalamic extracts in growth hormone release from rat pituitary in vito. Endocrinology,1968,83:783-790
[115] Brazeau P,Vale W,Burgus R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science,1973,179:77-79
[116] Rondeel J M,Jackson I M. Molecular biology of the regulation of hypothalamic hormones. J Endocrinol Invest,1993,16(3):219-246
[117] Goodman R H,Jacobs J W,Chin W W,et al. Nucleotide sequence of a cloned structural gene coding for a precursorof a pancreatic somatostatin. Proc Natl Acad Sci USA,1982,77:1682
[118] Chisholm C G,ReenbeRg G R. Somatostatin28 Regulates GLP1secretion via somatostatin receptor subtype 5 in rat intestinal cultures. Am J Physiol Endocrinol Metab,2002,283(2):311-317
[119] MitRa S W,Mezey E,Hunyady B,et al. Colocalization of somatostatin receptor SS5 and insulin in rat pancreatic β cell. Endocrinology,1999,140:3790-3796
[120] Pfeiffe R M,Koch T,SchRode R H,et al. Homo and heterodimerization of somatostatin receptor subtypes. J Biol Chem,2001,276(17):14027-14036
[121] Rocheville M,Lange D C,Kuma R U,et al. Receptors fo Rdopamine and somatostatin : formation of hetero oligomers with enhanced function alactivity. Science,2000,288(5463):154-157
[122] AfaRgan M,Janson E T,Gelerman G,et al. Novel long acting soma tostatin analog with endocrine selectivity:potent suppression of growth hormone but not of insulin . Endocrinology,2001,142:477-486
[123] Rajeswa RanW G,Hoca Rt S J,MuRphy W A, et al. Highly potent and subtype selective ligands derived by N-methylscan of a somatostatin an tagonist. J Med Chem,2001,44:1305-1311
[124] Belanger A,Labrie F,Borgeat P,et al. Immer H. Inhibition of growth hormone and thyrotropin release by growth hormone-release inhibiting hormone. Mol Cell Endocrinol,1974,1(5):329-339
[125] Kaneko T,Oka H,Munemure M,et al. Stimulation of guanosine 3',5’-cyclic monophosphate accumulation in rat anterior pituitary gland in vitro by synthetic somatostatin. Biochem Biophys Res Commun,1974,61(1):53-57
[126] Plotsky P M,Vale W. Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science,1985,230(4724):461-463
[127] Hodate K,Jhke T,Ozawa A,et al. Plasma growth hormone,insulin-like growth factor I , and milk production responses toe xogenous human growth hormone-releasing factor analogs in dairy cows . Endocrinol J pn,1990,37(2):261-273
[128] Pelletier G,Petitclerc D,Lapierre H,et al. Injection of synthetic human growth hormone-releasing factor in dairy cows.Effect on feed intake and milk yield and composition. J Dairy Sci,1987,70(12):2511-2517
[129] Enright W J,Zinn S A,Chapin L T. Growth hormone response of bull calves to growth hormone releasing factor.Proc Soc Exp Biol Med,1987,184(4):483-488
[130] Lapierre H,Tyrrell H F,Reynolds C K,et al. Effects on growth hormone-releasing factor and feed intake on energy metabolismin growing beefsteers:whole-body energy and nitrogen metabolis. J Anim Sci,1992,70(3):764-772
[131] Farmer C,Pommier S A,Brazeau P. Validation of a culture system for porcine pituitary cells:effects of growth hormone-releasing factor and(or)somatostatin on growth hormone secretion. J anim Sci,1993,71(4):923-929
[132] Dubreuil P,Petitclerc D,Pelletier G,et al. Effect of dose and frequency of administration of a potent analog of human growth hormone-releasing factor on hormone secretion and growth in pigs. J Anim Sci,1990,68(5):1254-1268.
[133] Johnson J T,Coffey M T,Esbenshade K L,et al. The effect of human growth hormone-releasing factor or porcine somatotropin on serum hormones and metabolites,growth performance and carcass traits in swine. J Anim Sci,1990,68(10):3204-3211
[134] Pommier S A,Dubreuil P,Pelletier G,et al. Effect of a potent analog of human growth hormone-releasing factor on carcass composition and quality of crossbred market pigs. J Anim Sci,1990,68(5):1291-1298
[135] Draghia-Akli R,Li X G,Schwartz R J. Enhanced Growth by ectopic expression of Growth hormone releasing hormone using an injectabele myogenic vector. Nat Biotechnol,1997,15:1285-1289
[136] Rusandra D A. Ecoptic GHRH Gene Expressed in Muscle and Increased Growth. Natur Biotech,1997,15:1285-1289
[137] Draghia-Akli R,Robert J A,Rusandra D A,et al.Myogenic expressed in muscle and increased Growth. Nature Biotechnol,1999,15:1179-1183
[138] 张永亮,欧阳红生,刘松财,等.生长激素释放因子(GHRH)在动物肌肉组织的表达.中国兽医学报,2000,(3):239~242
[139] 白忠彬,张永亮,田宝磊,等.原生质体介导的外源性 GHRH 基因在家兔体内的表达.华中农业大学学报,2002,21(6):509~511
[140] 任晓慧,张永亮,刘松财,等.微球包裹 pcDNA3-GHRH(1-32)在小鼠肌肉组织的表达及对生长的影响.生物工程学报,2004,20(4):615~618
[141] 张勇,周安国,吴德,等.仔猪骨骼肌注射 pGHRH 基因质粒的促生长及代谢调控效应研究.畜牧兽医学报,2003,34(2):147~151
[142] Khan,A S,Fiorotto M L,Cummings K K,et al. Maternal GHRH plasmid administration changes pituitary cell lineage and improves progeny growth ofpigs. Am. J. Physiol. Endocrinol. Metab,2003,285:224-231
[143] Draghia-Akli R,Fiorotto M L. A new plasmid-mediated approach to supplement somatotropin production in pigs. J. Anim. Sci,2004,82:264-269
[144] Meng Q Y,Chen Z Q,Yu Z Q,et al. Increased Body Weight Via Injecting Myogenic Expression Growth Hormone-Releasing Hormone(GHRH)Plasmid DNA into Sheep. Animal Biotechnology,2004,15(2):175-192
[145] 张利宇,孙宝忠,王敏.导入外源 GHRH 基因质粒对犊牛生长性能的影响.畜牧兽医科学,2006,22(9):10~13
[146] Fadlalla A M,Spencer G S G. The effect on passive immuniza -tion on against somatostatin on marker retention time in lambs. Journal of Animal Science,1985,61(1):234-238
[147] Maccecchini M L. Method of promoting animal growth using antibodies against somatostatin. U S Patent:4599,299.1986,7-8
[148] Sun Y X,Sinclair S E,Wynn P C,et al. Immunization against somatotrophn release inhibiting factor improves digestibity of food,growth and wool prodction of crossbred lambs. Aust J Agri Res,1990,41:401-411
[149] McCauley I,Billinghurst A,Morgan P O,et al. Manipulation of endogenou hormones to increase growth. Australasian Pig Science Association,1995:52-61
[150] Van Kessel A G,Laarveld B. Effect of passive immunization against somatostatin using a high-affinity antiserum on growth,IGF- I and thyroid hormone levels in neonatal lambs reared under warm or cold environmental conditions. Can J Anim Sci,1994,74:23-27
[151] Lawrence M E,Scheling G T,Byers F M,et al. Improvement of growth and feed efficiency in cattle by active immunization against somatostatin. J Anm Sci,1986,63(suppl):215
[152] Ingvartsen K L,Sejrsen K. Effect of immunization against somatatatin(ss)in cattle:a review of performance carcass composition and possible mode of action. Acta Agri Scandinavica(Section Animal Science),1995,45(45):124-131
[153] Trout W E,Schanbacher B D. Growth hormone and insulinlike growth factor-1 responses in steers actively immunized against somatostatin or growthhormone-releasing factor. J Endocrinol,1990,125:123-129
[154] Vicini J L,Clark J H,Hurley W L,et al. The effect of immunization against somatostatin on growth and concentration of somatotropin in plasma of Holstein calves. Domest Anim Endocrinol,1988,15(1):35-45
[155] Spencer G S G,Williamson E D. Increased growth of following irnmunization against somatostatin preliminary observations. Animal production,1981,32:376-383
[156] Spencer G S G. A novel approcehtogrouth promotion using auto immunisation against somatostatinIEffects on frowth an dhormone levels in lambs Livestock Priduction Science,1983(10):25-27
[157] Deligeorgis S G,Rogdakis E,Mentzios A,et al. Anote on the effect of active immunization against somatostatin on milk production and growth in sheep. Anim Prod,1988,46:304-308
[158] Van Kessel A G,Laarveld B,Acute or chronic immunoneutralization of somatostatin does not effect growth hormone or thyroid hormone secretion in sheep. J Endoc,1993,136:261-269
[159] Spencer G S G. Immuno-neutralization of somatostatin(ss) and its effects on animal production. Anim. Endocrinol,1986,3:55-68
[160] Mears G J. Immunization of lambs against somatostatin improve growth rate. Can J Anim Sci,1990,70:1091-1097
[161] Hoskinson R M,Djura P,Welch R J,et al. Failure of antisomatostatin antibodies to stimulate the growth of crossbred lambs. Aust J Exper Agri,1988,1222:1717-1725
[162] Varner M A,Davi S L,Reeves J J. Temporal serum concentrations of growth hrmone , thygrotropin , insulin glucagon in sheep immunized against somatoatatin. Endocrinology,1980,106:1027-1032
[163] 黄夺先,姚连生,赵伟,等.生长抑素主动免疫山羊的增重效果.江苏农业学报,1991,7(4):37~40
[164] Spencer G S G,Harvey S,Audsley A R,et al. The effect of immunization against somatostatin on growth rates and growth hormone secretion in the chicken. Comp Biochem Physiol A,1986,85(3):553-556
[165] Buonomo F C,Sabacky M J,Della-Fera M A,et al. Effects of somatostatinimmunoneutralization on growth and endocrine parameters in chickens. Domest Anim Endocrinol,1987,4(3):191-200
[166] Westbrook S L,Chandler K D,Mcdowell G H. Immunization of pregnant ewes against somatotrophin release inhibiting factor increases growth of twin-lambs. Aust J Agri Res,1993,44:229-238
[167] Westbrook S L,Ali A M,Mcdowell G H. Passively-acquired antibodies to somatostropin release inhibiting factor increases appetite and growth of milk-fed lambs. Aust J Agric Res,1994,45:293-302
[168] Farmer C,Dubreuil P,Pettclerc G,et a1. Active immunization against somatostatin in gestating gilts and the effect of transferred immunity on piglets. Can J Anim Sci,1990,70:211-218
[169] 曾义祥,杜念兴,汤锦炎.生长抑制激素基因在大肠杆菌中的表达.遗传学报,1991,18(3):282~288
[170] 徐文忠,李光地.生长抑素基因初级克隆质粒(pUC12—SS)的改造与鉴定.南京农业大学学报,1991,14(3):83~86
[171] 徐文忠,杜念兴,李光地,等.生长抑素基因与乙肝病毒表面抗原基因融合体质粒(pUC12-ss/HBs)的构建.南京农业大学学报,1992,15(02):83~88
[172] 徐文忠,杜念兴,李光地,等.促进动物生长的新型基因工程疫苗研究.中国科学 B 辑,1993,23(12):1272~1278
[173] 徐文忠,陈萍,杜念兴.基因重组痘苗病毒在鸡胚中的增殖与表达.南京农业大学学报,1994,17(2):126~127
[174] 蔡云珠,周建斌,邵长发,等.激生Ⅰ号免疫中国美利奴羊的增重试验.畜牧与兽医,2000,32(3):25~26
[175] 杜念兴,杨宏,吉传义,等.生长抑素基因工程苗活载体疫苗田间试验总结初报.畜牧与兽医,2001,33(2):23~24
[176] 王恩秀,陈伟华,杜念兴.生长抑素基因工程疫苗对大鼠生长及免疫的影响.中国兽医学报,2002,22(5):427~429
[177] 杜念兴,杨永军,王林云,等.激生Ⅰ号免疫中国美利奴羊的增重试验.畜牧与兽医,2000,32(3):25~26
[178] 孙元膀,王寿宽,赵中兴,等.激生 1 号疫苗免疫育肥猪低营养水平饲养增重试验.畜牧与兽医,2001(2):24~25
[179] 蔡云珠,王林云,杜念兴,等.一种新型的生长抑素活载体基因工程苗的构建及其动物免疫小试.中国畜牧杂志,1999,35(6):59~60
[180] 苏香林,李峰,王双.激生 1 号对生长育肥猪生长效果的试验观察.畜牧与兽医,2003(5):18~21
[181] 周鹏,严国祥,王全昌,等.激生 1 号免疫三元杂交肉猪的效果.畜牧与兽医,2003(2):18~19
[182] 王春凤,黄波,韦毕芬,等.激生 1 号免疫“内三元”育肥猪低能饲粮饲养试验.养猪,2006,2:24~25
[183] 骆永胜,林兆京.激生 1 号免疫三元杂交肉猪的试验报告.畜禽业,2005,8:32~33
[184] 徐国栋,刘长辉,李智红,等.“激生Ⅰ号”疫苗对猪增重效果的观察.2003,20,(5):61~62
[185] 莫晓群,崔治中,杜念兴.乙肝表面抗原和生长抑素融合基因在杆状病毒中表达.农业生物技术学报,1995,2:69~74
[186] 刘永庆,刘文波,潘杰彦,等.生长抑素(SS)基因在 pET-32 表达系统中的高效表达.南京农业大学学报,2003,26(1):61~65
[187] 刘永庆,陈溥言,杜念兴,等.生长抑素(SS)与硫氧还原蛋白(Thioredoxin)相融合生成的 2 种基因工程化融合蛋白 SS-N/X 和 SS-N/S 的表达特性.中国兽医学报,2003,23(2):172~176
[188] 陈溥言,杜念兴,赵国屏,等.生长抑素(SS)基因在大肠杆菌 pT7ZZ 表达系统中的克隆与表达.中国生物制品学杂志,2002,15(1):17~20
[189] 刘永庆,潘杰彦,陈溥言,等.生长抑素基因在大肠杆菌 pThioHis 表达系统中的克隆与表达.中国生物制品学杂志,2003,16(1):19~23
[190] 舒邓群,茆达干,吴志敏,等.以减毒沙门氏菌为载体的 GM-CSF 与生长抑素融合表达质粒对小鼠淋巴细胞增殖和 GH 及 IGF-Ⅰ分泌的影响.畜牧兽医学报,2006,37(8):814~818
[191] 戴贤君,方维焕.减毒沙门氏菌为载体的草鱼口服生长抑素 DNA 疫苗的构建及其稳定性.中国兽医学报,2005,25(4):356~358
[192] 何勤,张志荣,刘戟,等.载 TK 基因聚丙交酯乙交酯纳米粒的制备及有关性质研究.生物医学工程学杂志,2002,19(1):30~33
[193] 戴建威,刘松财,任晓慧,等.生长抑素与乙肝表面抗原真核表达载体构建及其对 Vc 獭兔生长的影响.中国兽医学报,2006,26(1):1~4
[194] 任晓慧,张永亮,刘松财,等.微球介导 GRF 基因在小鼠肌肉组织的表达及对增重的影响.生物工程学报,2004,20(4):615~618
[195] 张悦,戚晓红,冯振卿,等.免疫佐剂的研究进展.中国血吸虫病防治杂志,2004,16(3):236~238
[196] Xiao-Wen He,Fang Wang,Lei Jiang,et al. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg. Journal of General Virology,2005,86,601-610
[197] Lima K M,Santos S A,Lima V M,et al. Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis. Gene Ther,2003,10(8):678-685
[198] 刘松财,任晓慧,张明军,等.生长激素释放因子和垂体腺苷酸环化酶激活肽基因的共表达.科技导报,2006,24(8):36~39
[199] 杨瑞丽,金勇丰,吴玉澄,等.乙肝病毒表面抗原(HBsAg)基因工程疫苗的研究进展.药物生物技术,2002,9(1):53~56
[200] Valenzuela P,Medina A,Ruter W J. Synthesis and assembly of Hepatitis B virus surface antigen particles in yeast. Nature,1982,298:347-350
[201] Basu M,Dharm E,Levine J F,et al. Expression of Growth Homone-releasing Factor Analog Leu27GHRH(1-44)In Escherichia coli : Purification and Characterization of the Expresssed Protein. Arch. Biochem. Biophys.,1991,286(2):638-644
[202] Masahiro Iwakura,Kazuhiko Obara,Tomokuni Kokubu,et al. Expression and purification of Growth Hormone-releasing Factor With the Aid of Dihydrofolate Reductase Handle. J. Biochem.,1992,112:57-62
[203] 李伯良.牛生长激素释放因子的融合表达及其产物的化学加工.生物化学与生物物理学报,1994,26(6):577~583
[204] 王晓华,张娜,张娟辉,等.重组生长激素释放激素 GHRH 的纯化及活性测定.军医大学学报,2004,24(3):321~324
[205] Mehigh C S,Elias V D,Mehigh R J,et al. Development of a Recombinant Bovine Leukemia Vector for Delivery of a Synthetic Bovine Growth Hormone-releasing Factor Gene Into Bovine Cells. J Anim Sci,1993,71(3):687-693
[206] 曹少先,杨利国,茆达干,等.生长抑素基因疫苗 pcS/SS 构建及其在 HeLa细胞中的表达.中国兽医学报,2004,24(2):153~155
[207] Boyer J C,Haenni A L. Infectious transcripts and cDNA clones of RNA viruses. Virology,1994,198(2):415-426
[208] 余云舟,孙志伟,刘志刚,等.基于 DNA 的 Semliki 森林病毒复制子载体体内外高水平表达外源基因.生物化学与生物物理进展,2006,33(1):87~94
[209] 龚非,姜述德,李卫东,等.生物可降解微球作为乙型肝炎基因免疫佐剂的研究.微生物学通报,2001,28(2):68~72
[210] 胡云霞,原续波,康春生,等.同载基因和药物的超微载体粒子的制备及体外评价.高分子通报,2004,4:69~72
[211] 何勤,张志荣,刘戟,等.载 TK 基因聚丙交酯乙交酯纳米粒的性质及表达研究.药学学报,2004,39(4):285~287
[212] Corre P L,Guevello P L,Gajan v,et al. Preparation and characterization of bupivacaine-loaded polylactide and polylactide-co-glycolide micrpspheres. Int J Pharm,1994,107(1):41-49
[213] 金爱华,张寅恭,焦捷军,等.丙交酯乙交酯共聚物的毒性试验及其含左旋 18-甲基炔诺酮微球对鼠的抗生育作用研究.生物医学工程学杂志,2000,17(2):125~128
[214] Alpaslan C,Irie K,Takahashi K,et al. Long-term evaluation of recombinant human bone morphogenetic protein-induced bone formation with a biologic and synthetic delivery system. Br Joral and max illofac Surg,1996,34(5):414-418
[215] 刘善奎,高申,钟延强,等.DNA 疫苗微球给药系统的研究进展.中国药学杂志,2003,38(11):828~831
[216] Panyam J,Zhou W Z,Prabha S,et al. Rapid endo-lysosomal escape of poly(DL-lactide-coglycolide)nanoparticles : implications for drug and gene delivery. The FASEB Journal,2002,16:1217-1226
[217] Breier B H,Gluckman P D,Bass J J. Influence of status and oestradiol-17β on plasma growth hormone,Insulin-like factor-I and -II and response to exogenous growth hormone. Endocrinology,1988,118:243-250
[218] Draghia-Akli R. Myogenic expression of an injectable protease-resistant growth hormone-release hormone augments long-term growth in pigs. Natural Biotechnology,1999,17(1):51-54
[219] 任晓慧.GHRP-6和pcDNA3-GRF缓释微球的制备及对动物生长的影响:[硕士学位论文].长春:中国人民解放军军需大学,2004
[220] 王子荣,任明强,胥清富,等.生长抑素基因工程苗对绵羊外周血液某些代谢物浓度和激素水平的影响.畜牧兽医学报,2004,35(4):404~408
[221] Varner M A,Davis S L,Reeves J J. Temporal serum concent rat ions of growth hormone,thyroropin insulin and glucagon in sheep immunized against somatostat in. Endocrino logy,1980,106:1027-1032
[222] Trout W E,Schanbacher B D. Grow th hormone and insulin-like growth factor-I responses in steers actively immunized against somatostatin or growth hormone-releasing factor. Journal of Endocrinology,1990,125:123-129
[223] Dawson J M ,Soar J B,But tery P J,et al. The effect of immunization against somatostat in and B2agonist administ rat ion alone and in combination on grow th and carcass composition in young steers. Anim Sci,1997,64:37-51
[224] Magnan E,Mazzocchi L,Cataldi M,et al. Effect of actively immunizing sheep against rowth hormone releasing hormone or somatostatin on spontaneous pulsatile and neostigmine-induced growth hormone secretion.Endocrinology,1995,144:83-90
[225] Rehfeldt C,Kuhn G. Consequences of birth weight for postnatal growth performance and carcass quality in pigs as related to myogenesis. J Anim Sci,2006,84:113-123
[226] Harkins M,Boyd R D,and Bauman D E. Effect of recombinant porcine somatotropin on lactational performance and metabolite patterns in sows and growth of nursing pigs. J Anim Sci,1989,67:1997-2008
[227] Brown P A,Davis W C,Draghia-Akli R,et al. Immune-enhancing effects of growth hormone-releasing hormone delivered by plasmid injection and electroporation. Mol Ther,2004,10(4):644-651
[228] Thacker E L,Holtkamp D J,Khan A S,et al. Plasmid-mediated growth hormone-releasing hormone efficacy in reducing disease associated with Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus infection. J Anim Sci,2006,84:733-742
[229] 刘根桃,郑元林,陈伟华,等.妊娠后期母猪饲喂大豆黄酮对泌乳性能及初乳中激素水平的影响.南京农业大学学报,1998,22(1):69~71